Skip to main content
An official website of the United States government

Funded Grants

Grants awarded in the current fiscal year and carried over from prior fiscal years.

PI Name PI Organization Title Grant Number Initiative Program Official
Terry, Kathryn L.

Brigham And Women'S Hospital
United States

Changing Contraceptive Patterns and Ovarian Cancer Risk 5R01CA258679-05 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Goli Samimi, Ph.D., M.P.H.
Nappi, Lucia

Provincial Health Services Authority
United States

Integrating investigational miR371a-3p with conventional radiology imaging for earlier and more precise detection of active germ cell malignancy: A BCC/SWOG/S1823 secondary use of data collaboration. 5R37CA264798-03 PAR-19-264 (R01 Clinical Trial Optional) Guillermo Marquez, Ph.D.
Schedin, Pepper J

Oregon Health & Science University
United States

NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention 5R01CA169175-11 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Tayob, Nabihah

Dana-Farber Cancer Inst
United States

Biomarker screening algorithms for the improved early detection of hepatocellular carcinoma 5R01CA230503-07 Nicholas Hodges, Ph.D.
Robertson, Gavin P.

Pennsylvania State Univ Hershey Med Ctr
United States

Targeting Aldehyde Dehydrogenase for Cancer Prevention 5R01CA241148-05
Shelby, Rebecca A

Duke University
United States

Persistent Post-Mastectomy Pain: Randomized Clinical Trial of Targeted Pain Coping Skills Training (Targeted-PCST) with Mediational Analysis 5R01CA249959-05 Brennan Streck, Ph.D., RN, M.P.H.
Mallick, Parag Kumar

Stanford University
United States

Pathomic Predictors of Prostate Cancer Progression 5R01CA249899-05
Chen, Grace Y.

University Of Michigan At Ann Arbor
United States

Targeting cancer stem-like cells and inflammation for colon cancer chemoprevention 5R21CA273646-02
Nelson, Randy J.

West Virginia University
United States

Mechanism Underlying Sleep Disruption by Mammary Tumors 5R21CA276027-02 Marjorie Perloff, M.D.
Schmidt, Christian Maximillian

Indiana University Indianapolis
United States

Longitudinal Proteomic and Metabolomic Predictors of Pancreatic Cyst Malignant Progression and Early Stage Pancreatic Cancer 5U01CA239522-05 Claire Zhu, Ph.D.
Godwin, Andrew K.

University Of Kansas Medical Center
United States

Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered Microsystem 5R01CA260132-05 Matthew Young, Ph.D.
Chan, Andrew T

Massachusetts General Hospital
United States

Effects of inflammaging on intestinal epithelial cells and aspirin chemoprevention. 5R01CA257523-05 Asad Umar, D.V.M., Ph.D.
Zhu, Yong

Univ Of Arkansas For Med Scis
United States

Explore piRNAs as a novel group of biomarkers for ovarian cancer early detection 1R21CA277412-01A1 Christos Patriotis, Ph.D., M.Sc.
Eibl, Guido Erwin Michael

University Of California Los Angeles
United States

Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma 5P01CA236585-05
Hansen, Laura A

Creighton University
United States

Targeting aberrant anti-apoptotic signaling for prevention of skin cancer 5R01CA253573-05 Howard L. Parnes, M.D.
Richards-Kortum, Rebecca R.

Rice University
United States

Low-cost mobile colposcopy and confocal imaging for global prevention of cervical cancer 5R01CA251911-05 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Taratula, Oleh

Oregon State University
United States

Novel Nanomedicine-Based Therapeutic Approach For Treatment of Cancer Cachexia 5R37CA234006-07 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Kelleher, Sarah

Duke University
United States

Initial Testing of a Mobile App Pain Coping Intervention for Outpatient Oncology Settings 5R21CA273832-02 Brennan Streck, Ph.D., RN, M.P.H.
Pitteri, Sharon

Stanford University
United States

Glycosylation and Immune Evasion in Urologic Tumors 5U01CA226051-05
Liu, Changchun

University Of Connecticut Sch Of Med/Dnt
United States

Low-Cost CRISPR-on-Paper for Cervical Cancer Screening at the Point of Care 3U01CA269147-04S1 Christos Patriotis, Ph.D., M.Sc.
Frazier, Anne Lindsay

Dana-Farber Cancer Inst
United States

Assay Validation of a Circulating miRNA Test for Diagnosis and Monitoring of Malignant Germ Cell Tumors 5UH3CA240688-05 Nicholas Hodges, Ph.D.
Rosenberg, Daniel William

University Of Connecticut Sch Of Med/Dnt
United States

Microbiota, Metabolites, and Colon Neoplasia 5R01CA252045-05 Amit Kumar, Ph.D.
Barroilhet, Lisa M

University Of Wisconsin-Madison
United States

Repurposing Atovaquone for Preventing Ovarian Cancer: An Example of Successful Inhibition of Oxidative Phosphorylation 5R01CA238423-05 Goli Samimi, Ph.D., M.P.H.
Yilmaz, Omer

Massachusetts Institute Of Technology
United States

PROSPECT - Stem cell models 3OT2CA297570-01S1 Asad Umar, D.V.M., Ph.D.
Segata, Nicola

University Of Trento
United States

PROSPECT - Microbiome Studies. (PATHWAYS, RISK FACTORS, AND MOLECULES TO PREVENT EARLY-ONSET COLORECTAL TUMOURS) 1OT2CA297205-01 Asad Umar, D.V.M., Ph.D.
Huttenhower, Curtis

Broad Institute, Inc.
United States

PROSPECT: Pathways, Risk factors, and mOleculeS to Prevent Early-onset Colorectal Tumors 3OT2CA297578-01S1 Asad Umar, D.V.M., Ph.D.
Balskus, Emily Patricia

Harvard University
United States

PROSPECT: Pathways, Risk factors, and mOleculeS to Prevent Early-onset Colorectal Tumors 3OT2CA297577-01S1 Asad Umar, D.V.M., Ph.D.
Cao, Yin

Washington University
United States

PROSPECT-Global Consortium and Risk Factor Discovery 3OT2CA297576-01S1 Asad Umar, D.V.M., Ph.D.
Spector, Tim

King'S College London
United States

PROSPECT: Pathways, Risk factors, and mOleculeS to Prevent Early-onset Colorectal Tumors 1OT2CA297289-01 Asad Umar, D.V.M., Ph.D.
Chan, Andrew T

Massachusetts General Hospital
United States

MGH- PROSPECT: Pathways, Risk factors, and mOleculeS to Prevent Early-onset Colorectal Tumors 3OT2CA297680-01S1 Asad Umar, D.V.M., Ph.D.
Borges, Chad R

Arizona State University-Tempe Campus
United States

Plate reader assays to forensically assess exposure of plasma and serum to thawed conditions 5R21CA269091-03 RFA-CA-21-005 (R21 Clinical Trial Not Allowed) Indu Kohaar, Ph.D., M.Phil., M.Sc.
Carson, Tiffany Lashaun

H. Lee Moffitt Cancer Ctr & Res Inst
United States

Determining the structural- and functional-level effects of diet-specific interventions on the gut microbiota of a diverse sample of Southern United States adults 5R01CA253219-06 Young Kim, Ph.D.
Hruska, Carrie B

Mayo Clinic Rochester
United States

Density MATTERS Clinical Trial 5R01CA239200-05 Claire Zhu, Ph.D.
Oskeritzian, Carole A

University Of South Carolina At Columbia
United States

Novel modalities for prostate cancer screening: mast cells as predictors of disease, disease aggressiveness and marks of disease disparity 5R21CA274021-02 Guillermo Marquez, Ph.D.
Thakur, Mathew Laxman

Thomas Jefferson University
United States

Noninvasive, Uniplex, Molecular, Pathomic Urinary Assay for Detection of Prostate Cancer 5R01CA249921-05
Johnson, Constance Margaret

University Of Texas Hlth Sci Ctr Houston
United States

Auricular Point Acupressure to Manage Chemotherapy Induced Neuropathy 3R01CA245054-05S1 Rachel Altshuler, Ph.D.
Jim, Heather S.L.

H. Lee Moffitt Cancer Ctr & Res Inst
United States

Randomized Placebo Controlled Trial of Bupropion for Cancer Related Fatigue 5R01CA214647-05 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Bertozzi, Carolyn

Stanford University
United States

Chemical Glycoproteomics 5R01CA200423-22 Guillermo Marquez, Ph.D.
Chapkin, Robert Stephen

Texas A&M Agrilife Research
United States

Targeting plasma membrane spatial dynamics to suppress aberrant Wnt signaling 5R01CA244359-05 Amit Kumar, Ph.D.
Lokshin, Anna E

University Of Pittsburgh At Pittsburgh
United States

Development of Novel Ovarian Cancer Biomarkers for Early Detection Algorithms 5R01CA247220-05 Christos Patriotis, Ph.D., M.Sc.
Wang, Tza-Huei Jeff

Johns Hopkins University
United States

Development of a low-cost epigenetic screening assay for Pap specimen-based detection of early-stage ovarian cancer in high-risk women 5R01CA260628-05 Christos Patriotis, Ph.D., M.Sc.
Boyer, Thomas G

University Of Texas Hlth Science Center
United States

Pathological reprogramming of the m6A epitranscriptome in uterine fibroids 5R01HD106285-05 Goli Samimi, Ph.D., M.P.H.
Liu, Yang

University Of Illinois At Urbana-Champaign
United States

Imaging nanoscale chromatin folding in early carcinogenesis 5R01CA254112-07 Matthew Young, Ph.D.
John, Esther M.

Stanford University
United States

Stress, inflammation, and health-related quality of life of long-term breast cancer survivors 1R21CA290430-01 Brennan Streck, Ph.D., RN, M.P.H.
Tabung, Fred Kinyuy

Ohio State University
United States

Role of the inflammatory dietary pattern in gut and colon tissue microbiomes and impact on survival outcomes among colorectal cancer patients 1R21CA294050-01 Amit Kumar, Ph.D.
Taouli, Bachir

Icahn School Of Medicine At Mount Sinai
United States

Abbreviated MRI for HCC screening in cirrhotic patients 5R01CA249765-05 Guillermo Marquez, Ph.D.
Kumar, Nagi B.

H. Lee Moffitt Cancer Ctr & Res Inst
United States

Phase II Clinical trial of GTC in Men on Active Surveillance 5R01CA235032-06 Howard L. Parnes, M.D.
Chibwesha, Carla J

Univ Of North Carolina Chapel Hill
United States

Acceptability and feasibility of combination treatment for cervical precancer among South Africa women living with HIV 5R01CA250850-05 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Demehri, Shadmehr

Massachusetts General Hospital
United States

Immunosurveillance of breast glands with oncogenic germline mutations 5UG3CA290300-02 Altaf Mohammed, Ph.D.
Pena, Maria Marjorette

University Of South Carolina At Columbia
United States

The Role of Early Life Exposure to Antibiotics on Risk of Early Onset Colorectal Cancer 1R21CA281729-01A1
Shirwan, Haval

University Of Missouri-Columbia
United States

Developing a novel agonist of CD137 for cancer immunoprevention 5UG3CA290305-02 Altaf Mohammed, Ph.D.
NINA, BHARDWAJ,

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
United States

Immune determinants modulating cancer development in Lynch Syndrome 1UG3CA290517-01
Hall, Daniel Lee

Massachusetts General Hospital
United States

Innovating CBT-I for Cancer Survivors: An Optimization Trial 5R21CA279248-02
Martinez-Conde, Susana

Suny Downstate Medical Center
United States

Novel Perceptual and Oculomotor Heuristics for Enhancing Radiologic Performance 5R01CA258021-05 Guillermo Marquez, Ph.D.
Paulson, Thomas G

Fred Hutchinson Cancer Center
United States

The microbiome ecosystem of Barrett's esophagus and progression to cancer 5R21CA259687-02 PAR-20-292 (R21 Clinical Trial Optional) Matthew Young, Ph.D.
Kober, Kord Michael

University Of California, San Francisco
United States

An Investigation of the Molecular Mechanisms for and Prediction of the Severity of Cancer Chemotherapy-Related Fatigue Using a Multi-staged Integrated Omics Approach 5R37CA233774-07 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Kong, Mei

University Of California-Irvine
United States

Using dietary glutamine supplementation for melanoma prevention and targeted therapy 5R01CA244360-05 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Gabriela Riscuta, M.D., CNS
Svatek, Robert Scott

University Of Texas Hlth Science Center
United States

eRapa for bladder cancer prevention 5R01CA252057-05 PAR-19-183 (R01 Clinical Trial Optional) Howard L. Parnes, M.D.
Alambeigi, Farshid

University Of Texas At Austin
United States

A Novel Framework for Sensitive and Reliable Early Diagnosis, Topographic Mapping, and Stiffness Classification of Colorectal Cancer Polyps 5R21CA280747-02 Matthew Young, Ph.D.
Flory, James H

Sloan-Kettering Inst Can Research
United States

Managing metabolic disruption in pancreatic cancer to prevent weight loss and improve quality of life 5R21CA277464-02 Gabriela Riscuta, M.D., CNS
Winters-Stone, Kerri M

Oregon Health & Science University
United States

Patterns and predictors of symptoms, falls, and functioning across treatment and recovery in patients treated with neurotoxic chemotherapy for cancer 5R01CA248059-05 Goli Samimi, Ph.D., M.P.H.
Sieren, Jessica C

University Of Iowa
United States

Lung cancer screening efficacy enhanced through radiomic and epigenetic biomarkers 5R01CA267820-03 Nicholas Hodges, Ph.D.
Leal, Ana Sofia Mendes

Indiana University Indianapolis
United States

Nrf2, immune cells and lung cancer 7R01CA226690-06 Marjorie Perloff, M.D.
Mallery, Susan R

Ohio State University
United States

Assessment of Chemopreventive Effects of a Mucoadhesive Fenretinide Patch on Premalignant Oral Epithelial Lesions 5R01CA227273-06 Malgorzata Wojtowicz, M.D.
Linnes, Jacqueline

Purdue University
United States

Point-of-care screening test for early cervical cancer detection 5R01CA246315-05 Christos Patriotis, Ph.D., M.Sc.
Balaj, Leonora

Massachusetts General Hospital
United States

Standardized Molecular Analyses of Glioma EVs 5R01CA237500-05 Matthew Young, Ph.D.
Forsberg, Flemming

Thomas Jefferson University
United States

Prostate Cancer Diagnosis by Multiparametric Ultrasound 5R01CA252311-05
Somers, Tamara J

Duke University
United States

A Mobile Health Behavioral Pain Intervention Protocol for Breast Cancer Patients with Pain in Medically Underserved Communities: A Randomized Controlled Trial 5R01CA237892-05 Brennan Streck, Ph.D., RN, M.P.H.
Li, Feng

University Of California Los Angeles
United States

Novel ultra-short cell free DNA biomarkers for early detection of non-small cell lung cancer. 5R21CA283665-02 Guillermo Marquez, Ph.D.
Bettegowda, Chetan

Johns Hopkins University
United States

Interrogating malignant gliomas using released tumor DNA in cerebrospinal fluid 5R37CA230400-07 Sidney Fu, M.D.
Xu, Chunhui

Emory University
United States

High-throughput assessment of chemotherapy-induced cardiotoxicity in 3D human cardiomyocytes 1R21CA285254-01A1 Eileen Dimond, R.N., M.S.
Lesch, Bluma J

Yale University
United States

Defining signatures of epigenetic sensitization to lung cancer in a mouse model 5R21CA288677-02 Guillermo Marquez, Ph.D.
Mahan, Kristin Eckel

University Of Texas Hlth Sci Ctr Houston
United States

Circadian regulation of astrocytic adenosine kinase in the irradiated and cancer brain 1R21CA292148-01 John Clifford, Ph.D.
Harris, Holly Ruth

Fred Hutchinson Cancer Center
United States

Risk factors for and consequences of endometriosis among Black women 5R21HD115018-02 Goli Samimi, Ph.D., M.P.H.
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-11 Nicholas Hodges, Ph.D.
Hartman, Terryl J.

Emory University
United States

Fiber-rich Foods to Treat Obesity and Prevent Colon Cancer 5R01CA245063-05 Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Greene, Nicholas Perry

University Of Arkansas At Fayetteville
United States

DEVELOPMENT OF TARGETED APPROACHES IN PREVENTION OF CANCER-CACHEXIA 5R01AR075794-05 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Acciavatti, Raymond Joseph

University Of Pennsylvania
United States

Next-Generation Tomosynthesis Pilot Study 5R37CA273959-04 Asad Umar, D.V.M., Ph.D.
Barber, Glen N.

Ohio State University
United States

Development of A HTLV-1 Vaccine 7R01CA252049-05 Marjorie Perloff, M.D.
Hitchins, Megan P

H. Lee Moffitt Cancer Ctr & Res Inst
United States

Discovery and verification of methylated circulating tumor DNA markers for the detection of colorectal cancer in subjects under 50 years of age 7R01CA252042-05 Matthew Young, Ph.D.
Langevin, Anne-Marie R.

University Of Texas Hlth Science Center
United States

Texas Pediatric NCORP 3UG1CA189855-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Cohn, Barbara A

Public Health Institute
United States

Discriminatory Mechanisms in Early-Onset and Lethal Prostate Cancer 5R01CA264519-05 Howard L. Parnes, M.D.
Washington, Karla

Washington University
United States

Problem-Solving Therapy for Cancer Caregivers: A Randomized Clinical Trial in Outpatient Palliative Care 5R01CA258311-05 Brennan Streck, Ph.D., RN, M.P.H.
Curtis, Amarinthia E

Spartanburg Regional Medical Center
United States

Upstate Carolina Consortium - Community Oncology Research Program 3UG1CA239762-06S1 Vanessa A. White, M.P.H.
Salman, Emad

Florida Assn Of Pediatric Tumor Prog
United States

The Florida Pediatric NCORP: NCI Community Oncology Research Program. 3UG1CA189973-11S1 Vanessa A. White, M.P.H.
Whitman, Eric

Atlantic Health System, Inc.
United States

The Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC Corp) 3UG1CA239772-06S1 Vanessa A. White, M.P.H.
Milbury, Kathrin

University Of Tx Md Anderson Can Ctr
United States

Dyadic yoga Program for Patients with Lung Cancer Undergoing Radiotherapy and their Family Caregivers 4R37CA231522-07 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Skubitz, Amy Patrice

University Of Minnesota
United States

A paradigm shift for ovarian cancer biomarkers: Utilizing routine Pap tests as liquid biopsies for the development of targeted mass spectrometry-based proteomic assays for early detection 5R01CA262153-05 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Christos Patriotis, Ph.D., M.Sc.
Shalon, Tidhar Dari

Envivo Bio Inc
United States

Development and clinical evaluation of the CapScan gastrointestinal sampling device for metabolomics monitoring 5R33CA260665-04 Amit Kumar, Ph.D.
Paus, Ralf

University Of Miami School Of Medicine
United States

Pre-clinical testing of low intensity ultrasound as novel strategy to prevent paclitaxel-induced hair follicle damage in a humanized mouse model of chemotherapy-induced alopecia 1R21CA277418-01A1 Rachel Altshuler, Ph.D.
Fabian, Carol J.

University Of Kansas Medical Center
United States

Biomarker-Based Phase IIB Trial of (Bazedoxifene-Conjugated Estrogen) to Reduce Risk for Breast Cancer 5R01CA249437-05 Edward Sauter, M.D., Ph.D.
Ellsworth, Grant B.

Weill Medical Coll Of Cornell Univ
United States

Partnership for Prevention of HPV-Associated Cancers in People Living with HIV: Brazil, Mexico, and Puerto Rico 3U54CA242639-06S3 Maria Silvina Frech, Ph.D., M.S.
Young, Steven L

Duke University
United States

Collaborative Center to Develop Improved Diagnostic and Therapeutic Approaches to Endometriosis 5P01HD106485-05 Goli Samimi, Ph.D., M.P.H.
Williams, Paige L

Harvard University D/B/A Harvard School Of Public Health
United States

Pediatric HIV/AIDS Cohort Study (PHACS) 2020 3P01HD103133-05S1 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Deng, Youping

University Of Hawaii At Manoa
United States

Circulating lipid and miRNA markers for early detection of breast cancer among women with abnormal mammograms 5R01CA230514-05 Christos Patriotis, Ph.D., M.Sc.
Yendamuri, Saikrishna

Roswell Park Cancer Institute Corp
United States

Metformin for chemoprevention of lung cancer in obese subjects at high risk 5R01CA255515-05 Malgorzata Wojtowicz, M.D.
Khasabov, Sergey G

University Of Minnesota
United States

Treatment of cancer pain by lipid mediator Resolvin D1: role of Prostaglandin and Endocannabinoid signaling 5R01CA263777-05 Rachel Altshuler, Ph.D.
Toriola, Adetunji T

Washington University
United States

Targeting RANK Pathway in Mammographic Density and Primary Breast Cancer Prevention 5R37CA235602-07 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Singal, Amit

Ut Southwestern Medical Center
United States

Precision Risk Stratification and Screening for HCC among Patients with Cirrhosis in the United States 5U01CA230694-05
Acoba, Jared

University Of Hawaii At Manoa
United States

The Hawaii NCORP 3UG1CA189804-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Ellerton, John A

Southern Nevada Cancer Research Fdn
United States

NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Required) 3UG1CA189829-11S1 Vanessa A. White, M.P.H.
Gross, Howard M

Dayton Clinical Oncology Program
United States

Dayton Clinical Oncology Program 3UG1CA189957-11S1 Vanessa A. White, M.P.H.
Halmos, Balazs

Montefiore Medical Center (Bronx, Ny)
United States

Montefiore Academic Community NCORP Program 3UG1CA189859-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Schallenkamp, John M.

Montana Cancer Consortium
United States

Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming 3UG1CA189872-11S1 Vanessa A. White, M.P.H.
Kachnic, Lisa A.

Columbia University Health Sciences
United States

Columbia University NCI Community Oncology Research Program 3UG1CA189960-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Friday, Bret E.B.

Essentia Institute Of Rural Health
United States

Essentia Health Community Cancer Research Program - NCORP 3UG1CA189812-11S1 Vanessa A. White, M.P.H.
Baghdadi, Tareq Al

Saint Joseph Mercy Health System
United States

Michigan Cancer Research Consortium NCORP 3UG1CA189971-11S1 Vanessa A. White, M.P.H.
Caywood, Emi H

Nemours Children'S Hospital, Delaware
United States

Nemours NCI Community Oncology Research Program (NCORP) 3UG1CA189958-11S1 Vanessa A. White, M.P.H.
Ji, Yan

Healthpartners Institute
United States

Metro-Minnesota Community Oncology Research Consortium (MMCORC) 3UG1CA189863-12S1 Vanessa A. White, M.P.H.
Saphner, Thomas J

Aurora Health Care, Inc.
United States

Aurora NCORP Community Site 3UG1CA190140-11S1 Vanessa A. White, M.P.H.
Cantuaria, Guilherme

Northside Hospital Atlanta
United States

Georgia NCI Community Oncology Research Program (GA NCORP) 3UG1CA189997-11S1 Vanessa A. White, M.P.H.
Lesser, Glenn J

Wake Forest University Health Sciences
United States

Wake Forest NCORP Research Base 3UG1CA189824-11S2 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Osarogiagbon, Raymond U

Baptist Memorial Hospital - Tipton
United States

Baptist Memorial Health Care/Mid South NCORP Consortium 3UG1CA189873-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Remick, Scot C

Mainehealth
United States

MaineHealth Cancer Care Network (MHCCN) and NCORP Activities across the Lifespan 3UG1CA239771-06S1 Vanessa A. White, M.P.H.
Santos-Reyes, Luis Javier

Comprehensive Cancer Center/ Univ/Pr
United States

Puerto Rico NCI Community Oncology Research Program (Puerto Rico NCORP) 3UG1CA189862-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Milanovich, Samuel J.

Sanford Research/Usd
United States

Sanford Community Cancer Program of the North Central Plains (NCORP) 3UG1CA189825-11S1 Vanessa A. White, M.P.H.
Masters, Gregory A

Christiana Care Health Services, Inc.
United States

Delaware Christiana Care NCORP 3UG1CA189819-11S1 Vanessa A. White, M.P.H.
Adams-Campbell, Lucile Lauren

Georgetown University
United States

National Capital Area (NCA) NCI Community Oncology Research Program (NCORP) 3UG1CA239758-06S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Tamkus, Deimante

Cook County Health And Hospital System
United States

Stroger Hospital of Cook County (SHCC) NCORP 3UG1CA190000-12S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Irvin, William J

Southeast Clinical Oncol Res Consortium
United States

NCI Community Oncology Research Program 2025 Extension Request 3UG1CA189858-11S1 Vanessa A. White, M.P.H.
Butler, Kathleen Yost

Corewell Health
United States

Cancer Research Consortium of West Michigan (CRCWM) 3UG1CA189860-11S1 Vanessa A. White, M.P.H.
Marshall, David T.

Medical University Of South Carolina
United States

Medical University of South Carolina NCORP Community Site 3UG1CA189848-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Onitilo, Adedayo A

Marshfield Clinic Research Foundation
United States

Wisconsin NCI Community Oncology Research Program (WiNCORP) 3UG1CA189956-11S1 Vanessa A. White, M.P.H.
Vinciguerra, Vincent P

Feinstein Institute For Medical Research
United States

Northwell Health NCORP 3UG1CA189850-11S2 Vanessa A. White, M.P.H.
Panikkar, Rajiv

Geisinger Clinic
United States

Geisinger Cancer Institute - NCI Community Oncology Research Program (NCORP) 3UG1CA189847-11S1 Vanessa A. White, M.P.H.
Bruner, Deborah Watkins

Nrg Oncology Foundation, Inc.
United States

NRG Oncology NCORP Research Base-BIQSFP 3UG1CA189867-11S2 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Jaslowski, Anthony J

St. Vincent Hospital
United States

Cancer Research of Wisconsin and Northern Michigan (CROWN) Consortium 3UG1CA239769-06S1 Vanessa A. White, M.P.H.
Muller, Carolyn Y

University Of New Mexico Health Scis Ctr
United States

The NCI Community Oncology Research Program: The New Mexico NCORP 3UG1CA189856-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Carlson, Jay W

Ozark Health Ventures, Llc
United States

Ozark Health Ventures LLC dba Cancer Research for the Ozarks (CRO) 3UG1CA189822-11S1 Vanessa A. White, M.P.H.
Faller, Bryan

Decatur Memorial Hospital
United States

Heartland Cancer Research NCORP 3UG1CA189830-11S1 Vanessa A. White, M.P.H.
Suga, Jennifer Marie

Kaiser Foundation Research Institute
United States

Kaiser Permanente NCI National Community Oncology Research Program, NCORP 3UG1CA189821-11S1 Vanessa A. White, M.P.H.
Harichand, Seema

Iowa Oncology Research Association
United States

Iowa-Wide Oncology Research Coalition (I-WORC) 3UG1CA189816-11S1 Vanessa A. White, M.P.H.
Doolittle, Gary C.

University Of Kansas Medical Center
United States

The University of Kansas Cancer Center's- MCA Rural NCORP- extension 3UG1CA239767-06S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Matin, Khalid

Virginia Commonwealth University
United States

VCU Massey Comprehensive Cancer Center NCI Community Oncology Research Program 3UG1CA189869-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Drescher, Charles

Swedish Medical Center, First Hill
United States

The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site 3UG1CA189953-11S1 Vanessa A. White, M.P.H.
Siddique, Shahzad

Commonspirit Health Research Institute
United States

CIRI Oncology Research Alliance 3UG1CA189809-11S1 Vanessa A. White, M.P.H.
Ghamande, Sharad A.

Augusta University
United States

Georgia CaRes 3UG1CA189851-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Rowland, Kendrith Martin

Carle Foundation
United States

Carle Cancer Center NCI Community Oncology Research Program (NCORP) 3UG1CA189861-11S1 Vanessa A. White, M.P.H.
Rajagopalan, Malolan S

Columbus Community Clinical Oncology Prg
United States

Columbus NCORP RFA-CA-18-016 3UG1CA189954-11S1 Vanessa A. White, M.P.H.
Chung, Ki Young

Prisma Health - Upstate
United States

NCORP of the Carolinas (Greenville Health System NCORP) 3UG1CA189972-11S1 Vanessa A. White, M.P.H.
Md, Nicholas Dibella

Western States Cancer Research Ncorp
United States

NCORP: Colorado Cancer Research Program 3UG1CA189805-11S1 Vanessa A. White, M.P.H.
Blanke, Charles D.

Oregon Health & Science University
United States

SWOG NCORP Research Base 3UG1CA189974-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Paskett, Electra D.

Alliance Nctn Foundation
United States

Alliance NCORP Research Base 3UG1CA189823-11S3 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Wagner, Lynne I.

Ecog-Acrin Medical Research Foundation
United States

ECOG-ACRIN NCORP Research Base 3UG1CA189828-11S2 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Mustian, Karen M.

University Of Rochester
United States

URCC NCORP Research Base 3UG1CA189961-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Roth, Michael E.

Public Health Institute
United States

Children's Oncology Group NCI Community Oncology Research Program (NCORP) Research Base grant 3UG1CA189955-11S3 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Ochoa, Augusto C.

Lsu Health Sciences Center
United States

Gulf South Clinical Trials Network (Gulf South NCORP) 3UG1CA189854-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Barroilhet, Lisa M

University Of Wisconsin-Madison
United States

The MW Cancer Prevention Clinical Trials Network 5UG1CA242635-05 Donald Johnsey
Boone, Anna

University Of Missouri-Columbia
United States

Pilot testing of metacognitive strategy training to address cancer-related cognitive impairment in breast cancer 1R21CA286404-01A1 Marjorie Perloff, M.D.
Langel, Stephanie N.

Case Western Reserve University
United States

Antibody bound bacteria during HPV infection and cervical dysplasia 3R21CA289927-02S1 Goli Samimi, Ph.D., M.P.H.
Nguyen, Sang Minh

Vanderbilt University Medical Center
United States

Gut Microbiome Profiles in Association with Breast Cancer Recurrence and Mortality 1R03CA292953-01 Gabriela Riscuta, M.D., CNS
Palefsky, Joel Michael

University Of California, San Francisco
United States

California-Mexico-Puerto Rico Partnership (CAMPO) Center for Prevention of HPV-related Cancer in HIV+ Populations 3U54CA242646-06S3 Maria Silvina Frech, Ph.D., M.S.
Madeleine, Margaret M

Fred Hutchinson Cancer Center
United States

Colaboracion Evita: HPV-Related Cancer Prevention Partnership Center 3U54CA242977-07S4 Maria Silvina Frech, Ph.D., M.S.
Chong, Catherine Daniela

Mayo Clinic Arizona
United States

Biomarker Signature to Predict the Persistence of Post-Traumatic Headache 5R33NS113315-03 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Hur, Chin

Columbia University Health Sciences
United States

Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by Genotype 3R01CA257333-05S1 Matthew Young, Ph.D.
Marchand, Loic Le

University Of Hawaii At Manoa
United States

Effects of Intermittent Energy Restriction on Intra-Abdominal Fat and the Gut Microbiome: A Randomized Trial 5R01CA258179-05 RFA-CA-20-004 (R01 Clinical Trial Optional) Gabriela Riscuta, M.D., CNS
Ondrey, Frank G.

University Of Minnesota
United States

Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia 5R01CA254270-04 PAR-21-035 (R01 Clinical Trial Required) Malgorzata Wojtowicz, M.D.
Panda, Satchidananda

Salk Institute For Biological Studies
United States

Impact of Time-Restricted Feeding in Reducing Cancer Risk Through Optimizing Mitochondria Function 5R01CA258221-05 RFA-CA-20-004 (R01 Clinical Trial Optional) Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Hecht, Stephen S

University Of Minnesota
United States

High resolution mass spectrometric profile analysis of carcinogen-DNA adducts in oral cells of cigarette smokers and squamous cell carcinoma of the head and neck 5R01CA263084-05 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Wendy Wang, Ph.D., M.Sc.
Skates, Steven J

Massachusetts General Hospital
United States

Proteomic Analyses of Serial Prediagnostic PLCO Serum in Cases and Controls to Identify Early Detection Ovarian Cancer Biomarkers Rising in a Substantial Fraction of Cases and Stable in Most Controls 5U01CA260758-05 PAR-18-913 (U01 Clinical Trial Not Allowed) Claire Zhu, Ph.D.
Labaer, Joshua

Arizona State University-Tempe Campus
United States

Multiplex In-Solution Protein Array (MISPA) for high throughput, quantitative, early profiling of pathogen-induced head and neck 5R33CA281802-03 Wendy Wang, Ph.D., M.Sc.
Mungo, Chemtai

Univ Of North Carolina Chapel Hill
United States

Feasibility of artesunate to improve HPV and cervical precancer treatment outcomes among HIV positive women in LMICs 3R34CA284983-03S2 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Zarrinpar, Amir

University Of California, San Diego
United States

Engineering Native E. coli to Detect, Report, and Treat Colorectal Cancer 5U01CA265719-05 Guillermo Marquez, Ph.D.
Yang, Wan

Columbia University Health Sciences
United States

UNCOVER: underlying novel causes of onset of very early cancer research 5R01CA257971-05 Nicholas Hodges, Ph.D.
Melemedjian, Ohannes Kevork

University Of Maryland Baltimore
United States

Identification of novel targets for the treatment of chemotherapy-induced painful peripheral neuropathy 4R01CA249939-02 Rachel Altshuler, Ph.D.
Lee, Richard T

Beckman Research Institute/City Of Hope
United States

A Pilot Study to Evaluate the Benefits of Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy 1R21CA260447-01A1 Rachel Altshuler, Ph.D.
Hoshida, Yujin

Ut Southwestern Medical Center
United States

Reverse-engineering precision liver cancer chemoprevention 3R01CA233794-05S1 Marjorie Perloff, M.D.
Wang, Thomas D

University Of Michigan At Ann Arbor
United States

Early detection of colorectal cancer in the traditional and serrated pathways 5R01CA249851-05 Guillermo Marquez, Ph.D.
Ulrich, Cornelia M

Utah State Higher Education System--University Of Utah
United States

Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer link 5R01CA254108-05 Asad Umar, D.V.M., Ph.D.
Sanchez, Eduardo Vilar

University Of Tx Md Anderson Can Ctr
United States

Cancer Immune-Interception for Lynch Syndrome 5R01CA257375-05 Asad Umar, D.V.M., Ph.D.
Kahalley, Lisa Schum

Baylor College Of Medicine
United States

Comparison of Symptom Burden/Toxicity, Neurocognitive Change, and Functional Outcomes in Pediatric Brain Tumor Patients Treated with Proton vs. Photon Radiotherapy. 3R01CA249988-05S3 Rachel Altshuler, Ph.D.
Permuth, Jennifer B

H. Lee Moffitt Cancer Ctr & Res Inst
United States

Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Uncover Hidden Biology 5R37CA229810-07 Matthew Young, Ph.D.
Park, Youngkyu

Cold Spring Harbor Laboratory
United States

Preclinical Models for Cancer Therapeutic Development 5R50CA211506-10 Marjorie Perloff, M.D.
Hundley, William Gregory

Wake Forest University Health Sciences
United States

Improving Exercise Capacity with a Tailored Physical Activity Intervention in Lymphoma Patients Undergoing Treatment 5R33CA226960-05 Eileen Dimond, R.N., M.S.
Wang, Tza-Huei Jeff

Johns Hopkins University
United States

A low-cost, multiplexed digital high resolution melt platform for DNA methylation-based detection and identification of cancers in liquid biopsies 5R33CA272321-03 Christos Patriotis, Ph.D., M.Sc.
Li, Chi

University Of Louisville
United States

A lung cancer vaccine based on exosomes of induced pluripotent stem cells 1R21CA280453-01 John Clifford, Ph.D.
Ahn, Jiyoung

New York University School Of Medicine
United States

The Oral Mycobiome and Risk of Pancreatic Cancer 5U01CA250186-04 Claire Zhu, Ph.D.
Wang, Jing

New York University School Of Medicine
United States

Optimizing the use of ketamine to reduce chronic postsurgical pain 3UH3CA261067-05S1 Brennan Streck, Ph.D., RN, M.P.H.
Reb, Anne

Beckman Research Institute/City Of Hope
United States

A Blended e-Health Intervention for Fear of Progression in Advanced GYN Cancer 1R21CA293326-01 Brennan Streck, Ph.D., RN, M.P.H.
Burgess, Mark Thomas

Sloan-Kettering Inst Can Research
United States

Clinical assessment of radiotherapy-induced vaginal toxicity with multiparametric ultrasound imaging 5R21CA290252-02 Goli Samimi, Ph.D., M.P.H.
Lehto, Rebecca H

Henry Ford Health + Michigan State University Health Sciences
United States

Support for bereaved friend and family caregivers of cancer patients 1R03CA282943-01A1 Brennan Streck, Ph.D., RN, M.P.H.
Figueiredo, Jane C.

Cedars-Sinai Medical Center
United States

Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2 3U54CA260591-02S4 Christos Patriotis, Ph.D., M.Sc.
Li, Debiao

Cedars-Sinai Medical Center
United States

Predicting Pancreatic Ductal Adenocarcinoma (PDAC) Through Artificial Intelligence Analysis of Pre-Diagnostic CT Images 5R01CA260955-05 Matthew Young, Ph.D.
Schmit, Stephanie L.

Cleveland Clinic Lerner Com-Cwru
United States

Variation in tumor-associated immune profiles and colorectal cancer outcomes 5R01CA248931-05 Asad Umar, D.V.M., Ph.D.
Pozdeyev, Nikita

University Of Colorado Denver
United States

Genetic architecture of thyroid cancer and its clinical utility 5R21CA282380-02 Wendy Wang, Ph.D., M.Sc.
Bao, Ting

Dana-Farber Cancer Inst
United States

Yoga for Chemotherapy-induced Peripheral Neuropathy Treatment (YCT) Trial 5R01CA251470-06 Goli Samimi, Ph.D., M.P.H.
Tanasova, Marina

Michigan Technological University
United States

Molecular probes for targeting facilitative fructose transporters (GLUTs) in biochemical and biomedical applications 2R15CA242401-02A1 Wendy Wang, Ph.D., M.Sc.
Elenitoba-Johnson, Kojo S. J.

Sloan-Kettering Inst Can Research
United States

Genomic biomarkers of splenic lymphoma 5R01CA255655-06 Nicholas Hodges, Ph.D.
Storz, Peter

Mayo Clinic Jacksonville
United States

Deiminated molecules as markers for developing pancreatic cancer - A1 5R21CA279916-02 Matthew Young, Ph.D.
Rogers, Laura Q

University Of Alabama At Birmingham
United States

Role of gut microbe composition in psychosocial symptom response to exercise training in breast cancer survivors 5R01CA235598-06 Gabriela Riscuta, M.D., CNS
Peppone, Luke Joseph

University Of Rochester
United States

High-dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients 5R01CA258349-05 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Wang, Hsiao-Lan

University Of Alabama At Birmingham
United States

A Motion Exergaming Approach to Promote Self-Managing Fatigue and Pain after Head and Neck Cancer Treatment 5R01CA244947-06 Goli Samimi, Ph.D., M.P.H.
Sempere, Lorenzo

Michigan State University
United States

Image-Guided Intraductal Ablative Procedure for Primary Prevention of Breast Cancer 5R01CA258314-05 Edward Sauter, M.D., Ph.D.
Shiozawa, Yusuke

Wake Forest University Health Sciences
United States

Contribution of cutaneous neuro-immune interactions to chemotherapy-induced peripheral neuropathy 5R21CA297068-02 Rachel Altshuler, Ph.D.
Justilien, Verline

Mayo Clinic Jacksonville
United States

ECT2 Isoform Switch in Pancreatic Cancer. 5R21CA296671-02 Matthew Young, Ph.D.
Damaj, M. Imad

Virginia Commonwealth University
United States

Inhibition of NLRP3 inflammasome for the treatment of Chemotherapy-induced peripheral neuropathy 5R21CA296516-02 Rachel Altshuler, Ph.D.
Tong, Frank

Vanderbilt University
United States

Learning the visual and cognitive bases of lung nodule detection 5R01CA240274-06 Guillermo Marquez, Ph.D.
Fuschiotti, Patrizia

University Of Pittsburgh At Pittsburgh
United States

Develop IL13Ra1 for diagnosis of early-stage mycosis fungoides 5R21CA280445-02 Wendy Wang, Ph.D., M.Sc.
Phillips, Nicholas S

St. Jude Children'S Research Hospital
United States

Cardiopulmonary function and cerebral blood flow in Hodgkin Lymphoma survivors 5R21CA280230-02 Eileen Dimond, R.N., M.S.
Nicolson, Fay

Dana-Farber Cancer Inst
United States

SESORRS endoscopy for the staging and evaluation of colorectal cancer 5R00CA266921-05
Li, Bing

University Of Iowa
United States

E-FABP mediates n-3 fatty acid-induced tumor prevention through epigenetic control of immune cell differentiation and function 5R01CA180986-11 Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Tollefsbol, Trygve O

University Of Alabama At Birmingham
United States

Combinatorial epigenetic-based prevention of breast cancer 5R01CA178441-10 Gabriela Riscuta, M.D., CNS
Hanks, Brent Allen

Univ Of North Carolina Chapel Hill
United States

Role of the tumor NLRP3 inflammasome in the generation of anti-PD-1 antibody immunotherapy-associated toxicities 5R01CA251136-06 Marjorie Perloff, M.D.
Goncalves, Marcus Dasilva

New York University School Of Medicine
United States

Molecular Mechanisms of Fructose-induced Colorectal Cancer Cell Survival 5R01CA258697-06 Amit Kumar, Ph.D.
Fitzgibbon, Marian L.

University Of Illinois At Chicago
United States

Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer Risk 5R01CA250390-05 Young Kim, Ph.D.
Maclean, Paul S.

University Of Colorado Denver
United States

Novel dietary interventions for reducing obesity-associated breast cancer 5R01CA258766-05 Young Kim, Ph.D.
Zhu, Yazhen

University Of California Los Angeles
United States

Extracellular Vesicle-Based Digital Scoring Assay for Detecting Early-stage Hepatocellular Carcinoma 5R01CA255727-05 Matthew Young, Ph.D.
Li, Bo

Children'S Hosp Of Philadelphia
United States

Tracking Peripheral T-Cell Repertoire Changes for Preoperative and Early Ovarian Cancer Diagnosis 5R01CA258524-06 Christos Patriotis, Ph.D., M.Sc.
Ibsen, Stuart Duncan

Oregon Health & Science University
United States

Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers 5R37CA258787-05 Matthew Young, Ph.D.
Grossman, Douglas

Utah State Higher Education System--University Of Utah
United States

Electrical impedance dermography as a biomarker for basal and squamous cell carcinoma 5R21CA289101-02 Nicholas Hodges, Ph.D.
Suter, Melissa J

Massachusetts General Hospital
United States

Early Detection and Diagnosis of Lung Cancer with Endomicroscopy 5R01CA255326-04 Guillermo Marquez, Ph.D.
Welsh, Joellen

State University Of New York At Albany
United States

Vitamin K: Body Pools and Function in Breast Cancer 5R01CA258231-05 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Young Kim, Ph.D.
Stolley, Melinda R

Medical College Of Wisconsin
United States

Every Day Counts: A lifestyle program for women metastatic breast cancer 5R01CA258759-05 PAR-18-893 (R01 Clinical Trial Optional) Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Wei, Lei

Roswell Park Cancer Institute Corp
United States

Advancing skin cancer prevention by tackling UV-induced clonogenic mutations 5R01CA255242-05 Wendy Wang, Ph.D., M.Sc.
Palesh, Oxana G

Virginia Commonwealth University
United States

Multicenter Randomized Controlled Trial of Brief Behavioral Therapy for Cancer Related Insomnia 5R01CA239714-07 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Lokshin, Anna E

University Of Pittsburgh At Pittsburgh
United States

Urine and serum biomarkers for early diagnosis and risk assessment of pancreatic cancer 5R01CA254036-05 Matthew Young, Ph.D.
Sherman, Mark E

Mayo Clinic Jacksonville
United States

Targeted Prevention of Postpartum-Related Breast Cancer (PRBC) 5R01CA262393-05 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Esserman, Laura J

University Of California, San Francisco
United States

RISE UP for Breast Cancer 2026 1R13CA310705-01 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Deng, Gary E

University Of California-Irvine
United States

Acupuncture to Improve Outcomes in Patients with Sepsis: a Randomized Controlled Trial 7R21CA286330-03 Goli Samimi, Ph.D., M.P.H.
Beretta, Laura

University Of Tx Md Anderson Can Ctr
United States

Early Detection of Hepatocellular Carcinoma 5R01CA195524-09 Matthew Young, Ph.D.
Mello-Thoms, Claudia R

University Of Iowa
United States

Satisfaction of Search in Breast Cancer Detection 5R01CA259048-05
Clare, Susan E.

Northwestern University At Chicago
United States

Lipid-initiated epigenetic reprogramming of the breast to a neural phenotype 1R21CA288676-01A1
Cremer, Miriam

Cleveland Clinic Lerner Com-Cwru
United States

Single Visit Clinical Validation of ScreenFire, a Low-Cost HPV Test: Efficacy and Cost Effectiveness (SCALE) 5R01CA266059-04 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Kroetz, Deanna L

Ohio State University
United States

Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity 5R01CA261068-06 Rachel Altshuler, Ph.D.
Meghani, Salimah H.

University Of Pennsylvania
United States

Cannabis use and outcomes in ambulatory patients with cancer: A 12-month cohort study 3R01CA270483-04S1 PA-18-917 (R01 - Clinical Trial Optional) Gabriela Riscuta, M.D., CNS
Dhakal, Soma

Virginia Commonwealth University
United States

Single-Molecule High-Confidence Detection of miRNA Cancer Biomarkers 5R61CA278445-03 Christos Patriotis, Ph.D., M.Sc.
Spiegel, Brennan

Cedars-Sinai Medical Center
United States

Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes 5R01CA252211-05 Rachel Altshuler, Ph.D.
Webster, Nicholas J

Veterans Medical Research Fdn/San Diego
United States

The Effect of Time-Restricted Eating on the Efficiency of Chemo- and Hormonal-Therapy in Breast Cancer 5R21CA288777-02 Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Song, Ming

University Of Louisville
United States

Dietary fructose and NASH/HCC progression 5R21CA290420-02 Amit Kumar, Ph.D.
Jiang, Qing

Purdue University
United States

Anti-cancer effects of tocotrienols and a carboxychromanol in an innovative colon cancer model 5R03CA283236-02 Amit Kumar, Ph.D.
Huberty, Jennifer Lynne

University Of Texas Hlth Science Center
United States

Consumer-based meditation app, Calm, for treatment of sleep disturbance in hematological cancer patients 5R01CA262041-05 Marjorie Perloff, M.D.
Duan, Bin

University Of Nebraska Medical Center
United States

Flupirtine Analogue Synthesis and Screening for the Treatment of Chemotherapy-Induced Neuropathic Pain 1R21CA298918-01 Rachel Altshuler, Ph.D.
Jiang, Feng

Biotarget Dx Llc
United States

Plasma microRNA biomarkers for lung cancer diagnosis 7UH3CA251139-05 Guillermo Marquez, Ph.D.
Johnson, Jeremy James

University Of Illinois At Chicago
United States

Defining the role of isoprenylated xanthones from the mangosteen for enhancing degradation of full length and variant forms of androgen receptor in prostate cancer 5R37CA227101-07 Amit Kumar, Ph.D.
Clapper, Margie L.

Research Inst Of Fox Chase Can Ctr
United States

Folic Acid Supplementation and Colitis-associated Colon Carcinogenesis 5R01CA262551-04 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Shureiqi, Imad

University Of Michigan At Ann Arbor
United States

ALOX15 regulation of colon cancer invasiveness via PI3P-linoleic acid metabolism 5R01CA266223-04 Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Wallace, Douglas C

Children'S Hosp Of Philadelphia
United States

Anti-tumor immunity and intestinal microbiota are modulated by mitochondrial DNA 5R01CA259635-04 Young Kim, Ph.D.
Saenger, Yvonne Margaret

Albert Einstein College Of Medicine
United States

Applying pathomics to establish a biosignature for aggressive skin melanoma 5R01CA260375-05 Guillermo Marquez, Ph.D.
Grogan, Eric L

Vanderbilt University Medical Center
United States

Clinical Utility of Biomarkers Driven Management of Indeterminate Pulmonary Nodules 5R01CA252964-05 Claire Zhu, Ph.D.
Rao, Chinthalapally V.

University Of Oklahoma Hlth Sciences Ctr
United States

Discovery and Development of Natural Products for Interception of CRC 5UG3CA290310-02 Kajal Biswas, Ph.D.
Cao, Shugeng

University Of Hawaii At Hilo
United States

Discovery of novel natural TEAD inhibitors for the chemoprevention of liver tumors 5UG3CA290375-02 Altaf Mohammed, Ph.D.
Buszczak, Michael

Ut Southwestern Medical Center
United States

Developing ribosome biogenesis inhibitors for the prevention of cancer 5UG3CA290312-02 Kajal Biswas, Ph.D.
Livneh, Zvi

Weizmann Institute Of Science
United States

Analysis of the predictability of lung cancer using DNA Repair functional assays and cryopreserved blood samples of the PLCO prospective cohort 5U01CA279001-03 Claire Zhu, Ph.D.
Zi, Xiaolin

University Of California-Irvine
United States

Nautral products for targeting Skp2 in cancer interception 5UG3CA290368-02 Altaf Mohammed, Ph.D.
Salkowski, Lonie

University Of Wisconsin-Madison
United States

Defining and Optimizing Critical Interpretation Skills in Screening Mammography to Improve Cancer Detection 5R37CA262110-04 Guillermo Marquez, Ph.D.
Pistilli, Emidio Edward

West Virginia University
United States

Targeting Muscle Fatigability During Cachexia 5R01AR079445-04 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Kolb, Noah Allan

University Of Vermont & St Agric College
United States

Remote Monitoring of Management of Chemotherapy induced Peripheral Neuropathy 5R01CA247517-05 Brennan Streck, Ph.D., RN, M.P.H.
Ramanujam, Nirmala

Duke University
United States

Development and Validation of an Artificial-Intelligence-enabled Portable Colposcopy Device for Optimizing Triage Alternatives for HPV-based Cervical Cancer Screening 3U01CA269192-04S1 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Siminski, Suzanne M.

Frontier Sci & Technology Rsch Fdn, Inc
United States

CASCADE Coordinating Center 5U24CA275417-04 Maria Silvina Frech, Ph.D., M.S.
Winer, Rachel L.

University Of Washington
United States

The CASCADE CLIMB: Cervical cancer prevention in women Living with HIV research Mobilization Base 5UG1CA275402-04 Maria Silvina Frech, Ph.D., M.S.
Flowers, Lisa C.

Emory University
United States

Georgia Consortium to Eliminate Cervical Cancer in Women Living with HIV (GaCECC-WLWH) 5UG1CA284884-03 Maria Silvina Frech, Ph.D., M.S.
Chung, Michael Hoonbae

Emory University
United States

HIV/cervical cancer cOntrol and Prevention clinical sitE in Kenya (HOPE-Kenya) 3UG1CA275400-04S1 Maria Silvina Frech, Ph.D., M.S.
Naicker, Nivashnee

Centre/Aids Programme/Res/South Africa
United States

CAPRISA CASCADE Clinical Trials Network Clinical Research Site 5UG1CA284671-03 Maria Silvina Frech, Ph.D., M.S.
Wilkin, Timothy J.

University Of California, San Diego
United States

Partnership for advancing cervical cancer prevention in women living with HIV (CASCADE - Research Hub) 5UG1CA275414-05 Maria Silvina Frech, Ph.D., M.S.
Chirenje, Zvavahera Mike

University Of California, San Francisco
United States

Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Zimbabwe (ZIM-CASCADE) 3UG1CA284918-03S1 Maria Silvina Frech, Ph.D., M.S.
Mugo, Nelly Rwamba

Kenya Medical Research Institute (Kemri)
United States

KEMRI-PHRD UG1 CASCADE NETWORK UNIT: CERVICAL CANCER PREVENTION FOR WOMEN LIVING WITH HIV RESEARCH 3UG1CA285132-03S1 Maria Silvina Frech, Ph.D., M.S.
Mwesigwa, Betty

Makerere University Walter Reed Project
United States

Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Uganda (CASCADE UGANDA) 5UG1CA275412-04 Maria Silvina Frech, Ph.D., M.S.
Groninger, J. Hunter

Medstar Health Research Institute
United States

Cognitive behavioral theory-assisted virtual reality for chronic cancer pain (VR-CAN): device prototype development and feasibility testing 1R21CA299799-01 Brennan Streck, Ph.D., RN, M.P.H.
Pfleger, Cathie M

Icahn School Of Medicine At Mount Sinai
United States

A Drosophila model for Aromatase Inhibitor-induced Musculoskeletal Pain 1R21CA303409-01 Rachel Altshuler, Ph.D.
Miyano, Masaru

Beckman Research Institute/City Of Hope
United States

Evaluating the ELF5 Clock as a Biomarker in Breast Cancer Prevention Trials 1R03CA300614-01 Sidney Fu, M.D.
Shelby, Rebecca A

Duke University
United States

Improving outcomes for women experiencing premature or early menopause after cancer: development and pilot testing of a novel intervention 1R21CA301298-01 Goli Samimi, Ph.D., M.P.H.
Mallery, Susan R

Ohio State University
United States

Formulation, Evaluation, and Phase 0 Trial of Nanoparticle Releasing Oral Thin Film for OSCC Chemoprevention 5R01CA258757-04 Malgorzata Wojtowicz, M.D.
Elswick, Ronald K

Virginia Commonwealth University
United States

A Randomized Controlled Trial using a Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults with Cancer 5R01CA286799-03 Asad Umar, D.V.M., Ph.D.
Rini, Christine

Northwestern University At Chicago
United States

Web-based Pain Coping Skills Training to Improve Pain and Poor Adherence caused by Aromatase Inhibitor-Associated Arthralgia In Breast Cancer Survivors (SKIP-Arthralgia): A Randomized Controlled Trial 5R01CA271220-04 Brennan Streck, Ph.D., RN, M.P.H.
Adebamowo, Clement Adebayo

University Of Maryland Baltimore
United States

Baltimore CASCADE Study Site (BaCSS Project) 5UG1CA284883-03 Maria Silvina Frech, Ph.D., M.S.
Smith, Jennifer Susan

Univ Of North Carolina Chapel Hill
United States

UNC CASCADE Network Research Base 5UG1CA275403-04 Maria Silvina Frech, Ph.D., M.S.
Rubagumya, Fidel

Research For Development
United States

Rwanda CASCADE Clinical Trials Site for cervical cancer prevention 5UG1CA284908-03 Maria Silvina Frech, Ph.D., M.S.
Dryden-Peterson, Scott

Brigham And Women'S Hospital
United States

Botswana CASCADE Clinical Trials Site 3UG1CA275416-04S1 Maria Silvina Frech, Ph.D., M.S.
Caulin, Carlos

University Of Arizona
United States

Genetic Alterations That Confer High Risk to Oral Premalignant Lesions 5R01CA274857-04 PA-20-185 (Parent R01 Clinical Trial Not Allowed) John Clifford, Ph.D.
Hawkins, Shannon Michelle

Indiana University Indianapolis
United States

Targeting cellular senescence to inhibit the development and progression of ovarian endometriomas 5R01HD109707-04 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Goli Samimi, Ph.D., M.P.H.
Valdimarsdottir, Heiddis

Icahn School Of Medicine At Mount Sinai
United States

Systematic Light Exposure Effects on Circadian Rhythms Entrainment, Inflammation, Neutropenic Fever and Symptom Burden among Multiple Myeloma Patients undergoing Autologous Stem Cell Transplantation 5R01CA260961-04 PAR-21-035 (R01 Clinical Trial Required) Marjorie Perloff, M.D.
Sidransky, David

Johns Hopkins University
United States

Racial differences in Immunogenetic Tumorigenesis of Head and Neck Squamous Cell Carcinoma 5R01CA265975-04 Wendy Wang, Ph.D., M.Sc.
Ross, Stephen

New York University School Of Medicine
United States

Psilocybin Therapy for Advanced Cancer-related Psychiatric Distress 5R01CA268521-04 Rachel Altshuler, Ph.D.
Salvemini, Daniela

Saint Louis University
United States

Fingolimod and Ozanimod for the treatment and prevention of chemobrain 5R01CA261979-04 Rachel Altshuler, Ph.D.
Watt, Gordon Patrick

Netherlands Cancer Institute
United States

Quantitative background parenchymal enhancement, measured on contrast-enhanced mammogram, as a novel marker of breast cancer risk 3R37CA284134-03S1 Claire Zhu, Ph.D.
Huang, Ying

Western University Of Health Sciences
United States

Preventing UV-induced immunosuppression and skin carcinogenesis with R-carvedilol 5R01CA269653-04 Anda Vlad, M.D., Ph.D.
Buis, Lorraine R

University Of Michigan At Ann Arbor
United States

MyGI Diet for Colorectal Cancer Prevention 5R01CA255743-04 Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Cao, Yin

Washington University
United States

Obesity, sedentary behaviors, and diet quality for prevention and early detection of early-onset colorectal neoplasia 4R37CA246175-06 Asad Umar, D.V.M., Ph.D.
Liang, Han

University Of Tx Md Anderson Can Ctr
United States

The Cancer Proteome Atlas: an Integrated Bioinformatics Resource for Functional Cancer Proteomic Data 5U24CA264128-04 Christos Patriotis, Ph.D., M.Sc.
Lubman, David M.

University Of Michigan At Ann Arbor
United States

Serum Glyco-Markers of Early Hepatocellular Carcinoma Using a Mass Spec Approach 5R01CA160254-14 Matthew Young, Ph.D.
Bedrosian, Isabelle

University Of Tx Md Anderson Can Ctr
United States

Chimeric RNA driven neopeptide vaccine for prevention of breast cancer in germline BRCA1/2 carriers 1UG3CA290454-01A1 Altaf Mohammed, Ph.D.
El-Serag, Hashem B

Baylor College Of Medicine
United States

Prevention of Hepatocellular Carcinoma Related to Metabolic Syndrome 5P01CA263025-04 Asad Umar, D.V.M., Ph.D.
Sohl, Stephanie Jean

Wake Forest University Health Sciences
United States

REmotely-delivered Supportive Programs for Improving surgical pain and disTrEss (RESPITE) 5R01CA266995-04 PAR-21-035 (R01 Clinical Trial Required) Goli Samimi, Ph.D., M.P.H.
Goode, Diana J

University Of New England
United States

Novel expression of MHC class II on DRG neurons and its role in promoting antinociceptive CD4+ T cells in females during chemotherapy-induced peripheral neuropathy 5R01CA267554-04 Rachel Altshuler, Ph.D.
Sanchez, Eduardo Vilar

University Of Tx Md Anderson Can Ctr
United States

Cancer Immune-Interception in a Spontaneous Non-Human Primate Model of Lynch Syndrome 5R01CA260761-04 Asad Umar, D.V.M., Ph.D.
Singal, Amit

Ut Southwestern Medical Center
United States

Clinical Validation Center for Hepatocellular Carcinoma 5U01CA271887-04 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Lenburg, Marc Elliott

Boston University Medical Campus
United States

The Boston University - UCLA Lung Cancer Biomarker Characterization Center 5U2CCA271898-04 Guillermo Marquez, Ph.D.
Zheng, Yingye

Fred Hutchinson Cancer Center
United States

The Early Detection Research Network: Data Management and Coordinating Center 5U24CA086368-25 Guillermo Marquez, Ph.D.
Eldridge, Ronald C

Emory University
United States

Integrative Multi-Omics of Metabolomics and Epigenetics to Explore thePathophysiology of Cachexia and Survival in Head and Neck SquamousCell Carcinoma 1R03CA304028-01 Marjorie Perloff, M.D.
Vijayvergia, Namrata

Research Inst Of Fox Chase Can Ctr
United States

Exploring the Neuroprotective Potential of CBD in Preventing Oxaliplatin-Induced Neuropathy: A Prospective Study 1R21CA292276-01A1 Rachel Altshuler, Ph.D.
Dickinson, Sally E

University Of Arizona
United States

Investigating novel targets for topical immunoprevention of keratinocytic skin cancer 1UG3CA290443-01A1 Altaf Mohammed, Ph.D.
Li, Christopher I

Fred Hutchinson Cancer Center
United States

Fred Hutchinson Breast Cancer Clinical Validation Center 5U01CA152637-15 Sidney Fu, M.D.
Zhang, Zhen

Johns Hopkins University
United States

A multidisciplinary BCC for ovarian cancer early detection: translating discoveries to clinical use with a by-design approach 5U2CCA271891-04 Christos Patriotis, Ph.D., M.Sc.
Sun, Ju

University Of Minnesota
United States

SCH: A New Computational Framework for Learning from Imbalanced Biomedical Data 4R01CA287413-03 Claire Zhu, Ph.D.
Judge, Andrew Robert

University Of Florida
United States

The Complement System and Cancer Cachexia 5R01AR081648-04 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Grady, William Mallory

Fred Hutchinson Cancer Center
United States

Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagus 5U2CCA271902-04 Matthew Young, Ph.D.
Chinnaiyan, Arul M

University Of Michigan At Ann Arbor
United States

Michigan-VUMC Biomarker Characterization Center 5U2CCA271854-04 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Digirolamo, Gregory James

Univ Of Massachusetts Med Sch Worcester
United States

Increasing Nodule Detection in Lung Cancer by Non-Conscious Detection of "Missed" Nodules and Machine Learning 5R01CA269903-04
Sigel, Keith Magnus

Icahn School Of Medicine At Mount Sinai
United States

The effectiveness of screening women with lower genital tract neoplasia or cancers for anal cancer precursors 4R01CA256660-05 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Webster, Nicholas J

University Of California, San Diego
United States

Time-restricted feeding and breast cancer 5R01CA196853-09 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Infante, Rodney E

Ut Southwestern Medical Center
United States

Identifying the Cellular and Molecular Targets of JAK/STAT-Driven Adipose Wasting to Reverse Cancer Cachexia 3R01CA266900-04S1 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Marjorie Perloff, M.D.
Metzger, Gregory John

University Of Minnesota
United States

Computer Aided Diagnostic System for Prostate Cancer Detection Using Quantitative Multiparametric MRI 4R01CA241159-05 Guillermo Marquez, Ph.D.
Ghobrial, Irene M.

Dana-Farber Cancer Inst
United States

Molecular prediction of myeloma in African Americans 5U01CA271492-04 PAR-18-913 (U01 Clinical Trial Not Allowed) Claire Zhu, Ph.D.
Yeh, Jennifer M.

Boston Children'S Hospital
United States

Can risk-reducing medications improve breast cancer prevention in childhood and adolescent cancer survivors? Comparative modeling to inform care 5R01CA261874-04 Eileen Dimond, R.N., M.S.
Balu, Mihaela

University Of California-Irvine
United States

Fast, large area, multiphoton exoscope (FLAME) for improving early detection of melanoma 4R01CA259019-04 PAR-20-155 (R01 Clinical Trial Optional) Guillermo Marquez, Ph.D.
Eastham, James A

Sloan-Kettering Inst Can Research
United States

Influence of intra-individual variability in serial screening samples on clinical decision-making for risk stratification and biopsy by a single PSA and additional markers 5U01CA266535-04 PAR-18-913 (U01 Clinical Trial Not Allowed) Claire Zhu, Ph.D.
Grimm, Lars J

Duke University
United States

Dynamic imaging and tissue biomarker models to delineate indolent from aggressive breast calcifications 4R01CA271237-04 PAR-19-264 (R01 Clinical Trial Optional) Guillermo Marquez, Ph.D.
Yuan, Ying

University Of Tx Md Anderson Can Ctr
United States

Coordinating and Data Management Center for Translational and Basic Science Research in Early Lesions 5U24CA274212-04 RFA-CA-21-055 (U24 Clinical Trial Not Allowed) Christos Patriotis, Ph.D., M.Sc.
Plas, Ellen Van Der

Arkansas Children'S Hospital Res Inst
United States

Identifying markers of abnormal neurocognitive trajectories during chemotherapy treatment of childhood acute lymphoblastic leukemia 5R37CA266135-04 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Asad Umar, D.V.M., Ph.D.
Li, Yong

Baylor College Of Medicine
United States

Cancer Prevention-Interception Against MGUS Progression 5U54CA272691-03 Anda Vlad, M.D., Ph.D.
Tussing-Humphreys, Lisa

University Of Illinois At Chicago
United States

Effects of Time-restricted Eating versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers among Adults with Obesity 5R01CA257807-05 Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Wu, Yun

State University Of New York At Buffalo
United States

Lung Cancer Early Detection and Immunotherapy Response Prediction and Monitoring with an Exo-PROS Liquid Biopsy Assay 4R01CA272827-04 Christos Patriotis, Ph.D., M.Sc.
Robbins, Hilary A.

International Agency For Res On Cancer
United States

The Lung EArly Proteins project: A LEAP toward implementing biomarkers in lung cancer screening 4R01CA262164-04 Claire Zhu, Ph.D.
Cheville, Andrea Lynne

Mayo Clinic Rochester
United States

Achieving Safe, Comprehensive, Digitally-Enabled Cancer Pain managemeNT” (ASCENT) Clinical Trial 5R33CA278594-04 Brennan Streck, Ph.D., RN, M.P.H.
Markowitz, Sanford D.

Case Western Reserve University
United States

Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablation 5U01CA271867-04 Matthew Young, Ph.D.
Goggins, Michael G.

Johns Hopkins University
United States

Using markers to improve pancreatic cancer screening and surveillance: a multi-center study 5U01CA210170-09 Matthew Young, Ph.D.
Majumder, Shounak

Mayo Clinic Rochester
United States

Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer 5U01CA210138-09 Matthew Young, Ph.D.
Wolpin, Brian Matthew

Dana-Farber Cancer Inst
United States

Altered metabolism and machine learning for pancreatic cancer early detection 5U01CA210171-09 Matthew Young, Ph.D.
Grady, William Mallory

Fred Hutchinson Cancer Center
United States

Understanding adenoma progression: Interplay among tissue microenvironment, clonal architecture, and gut microbiome 3U54CA274374-04S2 Christos Patriotis, Ph.D., M.Sc.
Herman, James G.

University Of Pittsburgh At Pittsburgh
United States

Optimizing Ultrasensitive DNA methylation detection for lung cancer and other malignancies 5U2CCA271885-04 Wendy Wang, Ph.D., M.Sc.
Labaer, Joshua

Arizona State University-Tempe Campus
United States

High-throughput immunoproteomics for cancer biomarker discovery 5U2CCA271903-04 Christos Patriotis, Ph.D., M.Sc.
Semmes, Oliver John

Old Dominion University
United States

Virginia-UCLA-Toronto Biomarker Characterization Center 5U2CCA271894-05 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Amuta, Ann Oyare

University Of Texas Arlington
United States

Development of Tailored, Multilevel Cervical Cancer Interventions for Ethnically Diverse Black Women 1R15CA294297-01 Goli Samimi, Ph.D., M.P.H.
Ligibel, Jennifer A.

Dana-Farber Cancer Inst
United States

Distance-based Exercise to preserve Function and prevENt Disability (DEFEND) 5U34CA293568-02 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Knoerl, Robert James

University Of Michigan At Ann Arbor
United States

Determining the Feasibility of Virtual Tailored, Music-Based Relaxation for Anxiety Among Adolescent and Young Adult Cancer Survivors. 5R34CA286712-02 Goli Samimi, Ph.D., M.P.H.
Zhou, Xianghong Jasmine

University Of California Los Angeles
United States

Detecting and locating cancer for patients with CT-detected lung nodules 4R01CA264864-04 Guillermo Marquez, Ph.D.
Jim, Heather S.L.

H. Lee Moffitt Cancer Ctr & Res Inst
United States

Adaptation and Preliminary Evaluation of Energize-MBC: Cognitive Behavioral Therapy for Fatigue among Women with Metastatic Breast Cancer 5R34CA289918-02 Brennan Streck, Ph.D., RN, M.P.H.
Chan, Andrew T

Massachusetts General Hospital
United States

Precision Prevention Research Program 5R35CA253185-06 Asad Umar, D.V.M., Ph.D.
Rotemberg, Veronica Miriam

Sloan-Kettering Inst Can Research
United States

M-ISIC: A Multimodal Open-Source International Skin Imaging Collaboration Informatics Platform for Automated Skin Cancer Detection 5U24CA264369-04 Guillermo Marquez, Ph.D.
Oberg, Ann Laura

Mayo Clinic Rochester
United States

Management and Data Coordination Unit for PCDC 5U24CA274496-04 Guillermo Marquez, Ph.D.
Kalpathy-Cramer, Jayashree

University Of Colorado Denver
United States

AI algorithm development for cervical cancer screening in low resource settings 1R21CA305472-01 Nicholas Hodges, Ph.D.
Delaney, Joe R

Medical University Of South Carolina
United States

Biologic rationale of fallopian tube removal to prevent uterine serous carcinoma 1R21CA292343-01A1 Goli Samimi, Ph.D., M.P.H.
Clapper, Margie L.

Research Inst Of Fox Chase Can Ctr
United States

Cancer Prevention-Interception Targeted Agent Discovery Program at Fox Chase Cancer Center 5U54CA272686-04 John Clifford, Ph.D.
Slager, Susan L

Mayo Clinic Rochester
United States

The genetic and epigenetic etiology of progression from the precursor state to chronic lymphocytic leukemia (CLL) 4R01CA258465-04 Nicholas Hodges, Ph.D.
Mittal, Vivek

Weill Medical Coll Of Cornell Univ
United States

CAP-IT Center for LNP RNA Immunoprevention 5U54CA272688-04 John Clifford, Ph.D.
Farrar, Christian T

Massachusetts General Hospital
United States

Novel metabolomic contrast probes for human lung cancer characterization 4R01CA273010-04 Guillermo Marquez, Ph.D.
Hollingsworth, Michael A.

University Of Nebraska Medical Center
United States

Pancreatic Cancer Detection Consortium 5U01CA210240-09 Matthew Young, Ph.D.
Rosenbluth, Jennifer M.

University Of California, San Francisco
United States

In vitro models as a window to learn how to change outcomes in women at high risk of developing breast cancer 4R01CA281361-04 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Lu, Junxuan

Pennsylvania State Univ Hershey Med Ctr
United States

Early clinial trials for Angelica herbal supplements for prostate cancer interception 4R01CA260901-04 Gabriela Riscuta, M.D., CNS
Im, Eun-Ok

University Of Texas At Austin
United States

Cancer Pain Management: A Technology-Based Intervention for Asian American Breast Cancer Survivors 5R33CA280979-04 Brennan Streck, Ph.D., RN, M.P.H.
Maitra, Anirban

New York University School Of Medicine
United States

Clinical Validation Center for Early Detection of Pancreatic Cancer 7U01CA200468-09 Matthew Young, Ph.D.
Hoshida, Yujin

Ut Southwestern Medical Center
United States

Therapeutic modulation of a proteomic HCC risk signature with statins in patients with liver cirrhosis 4U01CA288375-03 Sidney Fu, M.D.
Lin, Jia-Ren

Harvard Medical School
United States

Advancing technologies for the collection and analysis of high dimensional immunoprofiles and tumor images 5R50CA274277-04 Guillermo Marquez, Ph.D.
Hanash, Samir M

University Of Tx Md Anderson Can Ctr
United States

Clinical Validation Center for Lung Cancer Early Detection 4U01CA271888-04 Guillermo Marquez, Ph.D.
Chung, Raymond T

Massachusetts General Hospital
United States

Trial of Statins for Chemoprevention in Hepatocellular Carcinoma 4R01CA255621-05 Asad Umar, D.V.M., Ph.D.
Zhao, Hua

University Of Virginia
United States

Homologous recombination repair capacity in peripheral blood lymphocytes as a breast cancer risk factor 4U01CA260731-04 Claire Zhu, Ph.D.
Ricciardiello, Luigi

University Of Tx Md Anderson Can Ctr
United States

Great Lakes New England Clinical Validation Center 4U01CA086400-24 Matthew Young, Ph.D.
Grogan, Eric L

Vanderbilt University Medical Center
United States

Clinical Utility of a Combined Biomarker Approach to Diagnose Lung Cancer 4U01CA152662-14 Guillermo Marquez, Ph.D.
Cocucci, Emanuele

Ohio State University
United States

A SYNTHETIC BIOMARKER TO UNIVERSALLY ASSESS THE RELATIVE CONTRIBUTION OF HEATHY AND CANCEROUS TISSUE TO CIRCULATING EV POOL 5R01CA270251-04 PAR-20-053 (R01 Clinical Trial Not Allowed) Matthew Young, Ph.D.
Stachler, Matthew D

University Of California, San Francisco
United States

Optimization and validation of a biomarker panel for risk stratification in Barrett's esophagus 5R37CA269649-04 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Matthew Young, Ph.D.
Huang, Ying

Fred Hutchinson Cancer Center
United States

Accelerating biomarker development through novel statistical methods for analyzing phase III/IV studies 5R01CA277133-04 Matthew Young, Ph.D.
Lee, Juhun

University Of Pittsburgh At Pittsburgh
United States

Detecting Mammographically-Occult Cancer in Women with Dense Breasts Using Digital Breast Tomosynthesis 5R01CA269540-04 Sidney Fu, M.D.
Pyter, Leah M

Ohio State University
United States

Chemotherapy-induced circadian master clock disruptions and fatigue 5R01CA270372-04 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Marjorie Perloff, M.D.
Staff, Nathan P

Mayo Clinic Rochester
United States

Investigating the role of MAP2 in chemotherapy-induced peripheral neurotoxicity 5R01CA275870-04 PAR-21-329 (R01 Clinical Trial Optional) Rachel Altshuler, Ph.D.
Mehrara, Babak J

Sloan-Kettering Inst Can Research
United States

Mechanisms of racial disparity in breast cancer-related lymphedema 5R01CA278599-04 Asad Umar, D.V.M., Ph.D.
Anderson, Garnet L.

Fred Hutchinson Cancer Center
United States

NCI Cancer Screening Research Network: Coordinating and Communication Center 5UG1CA286954-03 Elyse LeeVan, M.D., M.P.H.
Kooperberg, Charles L

Fred Hutchinson Cancer Center
United States

Statistics and Data Management Center (SDMC) for the NCI Cancer Screening Research Network (CSRN) 5UG1CA287013-03 Elyse LeeVan, M.D., M.P.H.
Doescher, Mark P

University Of Oklahoma Hlth Sciences Ctr
United States

Oklahoma TRUST Access Hub 5UG1CA287044-03 Elyse LeeVan, M.D., M.P.H.
Krist, Alexander H

Virginia Commonwealth University
United States

Virginia Cancer Screening Research Network Access Hub (Virginia CSRN Hub) 5UG1CA287017-03 Elyse LeeVan, M.D., M.P.H.
Lee, Jeffrey Kuang Zou

Kaiser Foundation Research Institute
United States

Multi-Cancer Early Detection and Screening (MED SCREEN) Study 5UG1CA287011-03 Elyse LeeVan, M.D., M.P.H.
Neslund-Dudas, Christine Marie

Henry Ford Health + Michigan State University Health Sciences
United States

HFH-MSU CSRN ACCrual Enrollment and Screening Site 5UG1CA287007-03 Elyse LeeVan, M.D., M.P.H.
Reuland, Daniel S.

Univ Of North Carolina Chapel Hill
United States

Cancer Screening Research Network - North Carolina Hub (CSRN-NC HUB) 5UG1CA286949-03 Elyse LeeVan, M.D., M.P.H.
James, Aimee S

Washington University
United States

Siteman Cancer Center Catchment CSRN ACCESS Hub 5UG1CA286946-03 Elyse LeeVan, M.D., M.P.H.
Cook, Linda S

University Of Colorado Denver
United States

Improving Strategies for Cancer Reduction through Early-detection and ENgagement (I-SCREEN) 5UG1CA286941-03 Elyse LeeVan, M.D., M.P.H.
Demb, Joshua Brian

University Of California, San Diego
United States

Optimal early colorectal cancer screening initiation 5R00CA267181-04 Claire Zhu, Ph.D.
Yu, Dihua

University Of Tx Md Anderson Can Ctr
United States

Exploring novel strategies for immunoprevention of estrogen receptor negative breast cancer 5R01CA270010-04 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Marjorie Perloff, M.D.
Ah, Diane Marie Von

Ohio State University
United States

Cognitive Training for Cancer-related Cognitive Impairment: A Multi-Center Randomized Controlled Trial 5R01CA276222-04 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Papachristodoulou, Alexandros

Rutgers Biomedical And Health Sciences
United States

Investigating mitochondrial dysfunction in high-risk prostate cancer 5R00CA276713-04 Anda Vlad, M.D., Ph.D.
Atigadda, Venkatram Reddy

University Of Alabama At Birmingham
United States

Development of Potent and non-toxic rexinoids to prevent non-melanoma skin cancer 5R01CA276683-03
Rosser, Charles J

Cedars-Sinai Medical Center
United States

A Multiplex Protein Biomarker-Based Immunoassay for the Early Detection of Bladder Cancer and its Implications in Tumor Biology 5R01CA277810-03 Guillermo Marquez, Ph.D.
Acharya, Munjal M

University Of California-Irvine
United States

Stem cell-derived exosomes to ameliorate chemobrain 5R01CA262213-03 PAR-21-329 (R01 Clinical Trial Optional) Rachel Altshuler, Ph.D.
Schoen, Robert E.

University Of Pittsburgh At Pittsburgh
United States

Blood-Based Testing for Advanced Adenoma 5U01CA271884-04 Matthew Young, Ph.D.
Kibel, Adam S

Brigham And Women'S Hospital
United States

Polygenic risk stratification combined with mpMRI to identify clinically relevant prostate cancer 5U01CA268810-03 Guillermo Marquez, Ph.D.
Diaz, Juan Sebastian Gomez

University Of California At Davis
United States

A miniaturized neural network enabled nanoplasmonic spectroscopy platform for label-free cancer detection in biofluids 3R01CA273253-03S1 Nicholas Hodges, Ph.D.
Brown, Austin L

Baylor College Of Medicine
United States

A Systems Epidemiology Approach for Predicting Methotrexate Neurotoxicity in Pediatric Acute Leukemia 5R01CA272981-03 Rachel Altshuler, Ph.D.
Damaj, M. Imad

Virginia Commonwealth University
United States

Targeting Sphingosine-1-phosphate (S1P1) receptors for the treatment of Aromatase Inhibitors-induced Musculoskeletal Symptoms 5R01CA272147-03 PAR-21-329 (R01 Clinical Trial Optional) Rachel Altshuler, Ph.D.
Dashwood, Roderick H

Texas A&M University Health Science Ctr
United States

Immunoepigenetic targeting of MHC regulators in FAP 5R01CA257559-03
Spellman, Paul T.

University Of California Los Angeles
United States

Germline Determinants of Prostate Cancer Evolution 5R01CA270108-03 Guillermo Marquez, Ph.D.
Brand, Randall

University Of Pittsburgh At Pittsburgh
United States

Validation of biomarkers for risk prediction and early diagnosis of Pancreatic Adenocarcinoma 5U01CA200466-08 Matthew Young, Ph.D.
Sears, Rosalie C

Oregon Health & Science University
United States

Validation of novel imaging and molecular tests for early detection of pancreatic cancer through risk-stratified community engagement programs 5U01CA278923-03 PAR-21-334 (U01 Clinical Trial Optional) Matthew Young, Ph.D.
Segal, Leopoldo Nicolas

New York University School Of Medicine
United States

Microbial and host biomarker development for detection and prognosis of early stage non-small cell lung cancer 5U2CCA271890-03 Guillermo Marquez, Ph.D.
Yu, Anthony Francis

Sloan-Kettering Inst Can Research
United States

Intensive Blood Pressure Control During Cardiotoxic Breast Cancer Treatment (PROTECT) Trial 5R37CA273923-03 PAR-21-329 (R01 Clinical Trial Optional) Eileen Dimond, R.N., M.S.
Sukumar, Saraswati

Johns Hopkins University
United States

Development of an automated, point of care DNA methylation cartridge blood test for colorectal cancer detection in LMICs- an academic-industrial partnership 3R01CA278816-03S1 Matthew Young, Ph.D.
Shah, Sohrab P

Sloan-Kettering Inst Can Research
United States

Exploiting markers of genomic instability in high-risk pre-invasive ovarian cancer 5R01CA281928-03 Christos Patriotis, Ph.D., M.Sc.
Paulovich, Amanda G

Fred Hutchinson Cancer Center
United States

Breast-cancer focused biomarker characterization center employing targeted mass spec assays in a CLIA environment 5U2CCA271873-03 Sidney Fu, M.D.
Buczynski, Matthew Wallace

Virginia Polytechnic Inst And St Univ
United States

Anti-nociceptive actions of CART II in chemotherapy-induced peripheral neuropathy 5R01CA284075-03 Rachel Altshuler, Ph.D.
Duvall, Adam S.

University Of Chicago
United States

Tailoring a fun and engaging tech-assisted cognitive behavioral therapy program for adolescents and young adults with hematological malignancies: A planning grant 1R34CA297498-01 Brennan Streck, Ph.D., RN, M.P.H.
Brinkman, Tara M

St. Jude Children'S Research Hospital
United States

Culturally adapted mobile treatment of chronic pain in adolescent survivors of pediatric bone sarcoma 4R33CA280978-02 Rachel Altshuler, Ph.D.
Bast, Robert C

University Of Tx Md Anderson Can Ctr
United States

MD Anderson Cancer Center EDRN- Clinical Validation Center for Early Detection of Ovarian Cancer with a multiple marker algorithm 5U01CA200462-08 Christos Patriotis, Ph.D., M.Sc.
Thangaraju, Muthusamy

Augusta University
United States

Bacteria-derived xenobiotics in colon cancer prevention: Link to GPR109A and colonic ketogenesis 5R01CA275840-03 John Clifford, Ph.D.
Hilakivi-Clarke, Leena A.

University Of Minnesota
United States

Effect of maternal obesity on breast cancer among offspring: role of the gut microbiota 5R01CA276775-03 Amit Kumar, Ph.D.
Chan, Daniel Wanyui

Johns Hopkins University
United States

Development of a panel of multiplex biomarkers for the early detection of pancreatic ductal adenocarcinoma and high-risk lesions 5U01CA274514-03 PAR-21-334 (U01 Clinical Trial Optional) Matthew Young, Ph.D.
Zhu, Yazhen

University Of California Los Angeles
United States

Click Chemistry-Mediated Surface Protein Assay for Quantifying Subpopulations of Hepatocellular Carcinoma-associated Extracellular Vesicles 5R01CA277530-03 Matthew Young, Ph.D.
Bhatt, Vijaya Raj

University Of Nebraska Medical Center
United States

Aging trajectories and outcomes of older adults with acute myeloid leukemia 5R37CA276928-03 Brennan Streck, Ph.D., RN, M.P.H.
Yaghjyan, Lusine

University Of Florida
United States

Stromal contributions to breast carcinogenesis 5R01CA277817-03 Christos Patriotis, Ph.D., M.Sc.
Freedland, Stephen Jay

Cedars-Sinai Medical Center
United States

Intermittent Fasting using a Fasting-Mimetic Diet to Improve Prostate Cancer Control and Metabolic Outcomes 3R01CA280081-03S1 Young Kim, Ph.D.
Chan, Daniel Wanyui

Johns Hopkins University
United States

BCC for Prostate Cancer: Discovery and Translation of Biomarkers for Clinical Unmet Needs 5U2CCA271895-03 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Mclouth, Laurie

University Of Kentucky
United States

Pathways, a Hope-Based Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life during Advanced Lung Cancer Treatment 5R01CA283929-03 Brennan Streck, Ph.D., RN, M.P.H.
Allen, Peter J

Duke University
United States

Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas 5R01CA182076-08 Matthew Young, Ph.D.
Punnen, Sanoj

University Of Miami School Of Medicine
United States

The Rigor and Clinical Utility of PSMA Enriched Extracellular Vesicles for Prostate Cancer Detection 5R01CA272766-03 Matthew Young, Ph.D.
Hu, Shuiying

Ohio State University
United States

Targeting neuronal transport to ameliorate vincristine neurotoxicity 5R01CA272254-03 Rachel Altshuler, Ph.D.
Velculescu, Victor E.

Johns Hopkins University
United States

DNA evaluation of fragments for early interception (DELFI) of Lung cancer 5U01CA271896-03 Guillermo Marquez, Ph.D.
Sanda, Martin G

Emory University
United States

Prostate Cancer Biomarker and Imaging Validation Alliance: Emory University, University of Alabama Birmingham, and University of Texas Southwestern 5U01CA113913-18 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Moses, John Edward

Cold Spring Harbor Laboratory
United States

Discovery of Natural Products and Natural Product Derivatives as Inhibitors of KLK6 to Prevent the Progression of Preneoplastic Ductal Pancreatic Cancer 1UG3CA290364-01A1 Altaf Mohammed, Ph.D.
Penedo, Frank J

University Of Miami Coral Gables
United States

eHealth Supported Mindfulness-based Music Therapy Intervention (eMBMT) in Hemopoietic Stem Cell Transplant Patients 4R33CA263335-03 Asad Umar, D.V.M., Ph.D.
Castro, Cesar M

Massachusetts General Hospital
United States

Composing CODAs to cervical cancer screening through an integrated CRISPR and fluorescent nucleic acid approach 3U01CA279858-03S2 Christos Patriotis, Ph.D., M.Sc.
Pinder, Leeya F

University Of Cincinnati
United States

RepurPosed AntiretrOviraL ThErapieS to EliminAte Cervical Cancer (POLESA Trial) 3R37CA284033-03S1 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Lampe, Paul D.

Fred Hutchinson Cancer Center
United States

Autoantibodies to tumor-derived neoepitopes as biomarkers and immunoPET agents for the early detection of small cell lung cancer 5R01CA281801-03 Guillermo Marquez, Ph.D.
Morilak, David A

University Of Texas Hlth Science Center
United States

Therapy-induced cognitive impairment in a rat model of prostate cancer 5R01CA285183-03 John Clifford, Ph.D.
Bryan, Angela

University Of Colorado
United States

Cannabis for Palliative Care in Cancer: A Placebo-controlled Randomized Trial of Full Spectrum Hemp-derived CBD/THC 5R01CA284860-03 Brennan Streck, Ph.D., RN, M.P.H.
Anderson, Karen Sue

Arizona State University-Tempe Campus
United States

Southwest EDRN Clinical Validation Center for Head and Neck Cancer 5U01CA281660-03 Wendy Wang, Ph.D., M.Sc.
Lindau, Stacy Tessler

University Of Chicago
United States

Bionic Breast Project: A Neuroprosthesis to Restore Touch Sensation and Reduce Chronic Pain After Mastectomy 5R01CA281301-03 Marjorie Perloff, M.D.
Schroeck, Florian R

Veterans Education/Res/Assn/North/Ne
United States

Replacing Invasive Cystoscopy with Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance 5R37CA275916-03 Claire Zhu, Ph.D.
Goel, Ajay

Beckman Research Institute/City Of Hope
United States

Exosomal biomarkers for the early detection of hepatocellular carcinoma 5R01CA271443-03 Matthew Young, Ph.D.
Afshar-Kharghan, Vahid

University Of Tx Md Anderson Can Ctr
United States

Novel Biomarkers Predicting Blood Clots in Ovarian Cancer 5R01CA275762-03 Rachel Altshuler, Ph.D.
Nabavi, Sheida

University Of Connecticut Storrs
United States

SCH: Robust Multimodal Longitudinal AI for Enhanced Breast Cancer Screening 5R01CA297855-02 Claire Zhu, Ph.D.
Basu, Partha

International Agency For Res On Cancer
United States

A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICs 3R37CA275824-03S2 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Salami, Simpa Samuel

University Of Michigan At Ann Arbor
United States

Defining the Biological Arc of Grade Group 1 Prostate Cancer 5R37CA283857-03 Guillermo Marquez, Ph.D.
Hebert, James R

University Of South Carolina At Columbia
United States

A Transdisciplinary Approach to Investigating Metabolic Dysregulation in Obese Parent and Child Dyads and Risk of Colorectal Cancer 3U01CA272977-03S1 Gabriela Riscuta, M.D., CNS
Kresty, Laura A

University Of Michigan At Ann Arbor
United States

Developing Natural Products to Target IL-8 Signaling and Intercept Progression of Barrett’s Esophagus to Esophageal Adenocarcinoma 1UG3CA299397-01 Altaf Mohammed, Ph.D.
Hu, Jim

Weill Medical Coll Of Cornell Univ
United States

Pelvic fascia spARing radical prostatectomy TrIAL (PARTIAL) 5R01CA259173-04 Marjorie Perloff, M.D.
Olopade, Olufunmilayo F.

University Of Chicago
United States

The Funding Mechanism of the Pilot Trial 5R01CA276652-03 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Goel, Ajay

Beckman Research Institute/City Of Hope
United States

Exosome-based microRNA biomarkers for Non-invasive and Early Detection of Pancreatic Cancer 3U01CA214254-08S2 Matthew Young, Ph.D.
Iwelunmor, Juliet

Washington University
United States

Innovative Rapid Enabling, Affordable, point-of-Care HPV Self-Testing Strategy (I-REACH) 3U01CA279863-04S1 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Hill, Joshua Aiden

Fred Hutchinson Cancer Center
United States

Immunoglobulin Replacement Therapy and Infectious Complications After CD19-Targeted CAR-T-Cell Therapy 5R01CA276040-03 Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Alexandrov, Ludmil B

University Of California, San Diego
United States

Mapping immuno-genomic drivers of the head and neck precancer invasive-disease transition 5U01CA290479-03 Wendy Wang, Ph.D., M.Sc.
Ji, Hanlee P

Stanford University
United States

Precision Interception of Gastric Cancer Precursors Through Molecular and Cellular Risk Stratification 5P01CA265772-03 Asad Umar, D.V.M., Ph.D.
Zheng, Yingye

Fred Hutchinson Cancer Center
United States

Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit 5U24CA288185-03 Guillermo Marquez, Ph.D.
Ghosh, Jayashri

Temple Univ Of The Commonwealth
United States

Development of blood-based methylation biomarkers for CRC risk prediction 5R01CA281948-03 Matthew Young, Ph.D.
Fahrmann, Johannes F

University Of Tx Md Anderson Can Ctr
United States

Blood-Based Biomarkers for Personalized Risk Assessment of Breast and Ovarian Cancer 5U01CA282216-03 Claire Zhu, Ph.D.
Taouli, Bachir

Icahn School Of Medicine At Mount Sinai
United States

Liquid biopsy and radiomics for liver cancer surveillance 4U01CA283931-03 Sidney Fu, M.D.
Curtius, Kathleen M.

University Of California, San Diego
United States

Multiscale modeling of spatiotemporal evolution in Barrett's esophagus 5R01CA270235-03 Asad Umar, D.V.M., Ph.D.
Kim, Hyung L

Cedars-Sinai Medical Center
United States

Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer 5R01CA280060-03 Howard L. Parnes, M.D.
Gudas, Lorraine J

Weill Medical Coll Of Cornell Univ
United States

CD 1530, an RAR Gamma Agonist for Oral Cavity Squamous Cell Carcinoma Prevention 5R01CA270248-03 Anda Vlad, M.D., Ph.D.
Yu, Danxia

Vanderbilt University Medical Center
United States

Gut microbiota-related mechanisms that impact colorectal cancer risk after bariatric surgery 5R01CA275864-03 Edward Sauter, M.D., Ph.D.
Chan, Alexandre

University Of California-Irvine
United States

Neurotrophic strategy to mitigate chemotherapy-related brain injury 5R01CA276212-03 PAR-21-329 (R01 Clinical Trial Optional) John Clifford, Ph.D.
Chak, Amitabh

Case Western Reserve University
United States

Pathways of Injury and Repair in Barrett's Carcinogenesis 5P01CA269019-03 Asad Umar, D.V.M., Ph.D.
Lyden, David Charles

Weill Medical Coll Of Cornell Univ
United States

Application of 4D proteomics and super-resolution microscopy in extracellular vesicle and particle-borne biomarker discovery for early pancreatic cancer detection 5R01CA218513-08 Matthew Young, Ph.D.
Sedrak, Mina S

University Of California Los Angeles
United States

Targeting Senescence to Mitigate Chemotherapy-induced Functional Decline 5R01CA280088-03 Goli Samimi, Ph.D., M.P.H.
Zhou, Xianghong Jasmine

University Of California Los Angeles
United States

The UCLA Center in Early Detection of Liver Cancer 5U01CA230705-08 Sidney Fu, M.D.
Lee, Hakho

Massachusetts General Hospital
United States

Expanding early cancer detection with high throughput OCEANA - Ovarian Cancer Exosome Analysis with Nanoplasmonic Array 5U01CA284982-03 Nicholas Hodges, Ph.D.
Kanwal, Fasiha

Baylor College Of Medicine
United States

Risk Stratification for and Early Detection of Liver Cancer 5U01CA230997-08 Sidney Fu, M.D.
Fiol, Guilherme Del

Utah State Higher Education System--University Of Utah
United States

GARDE: Scalable Clinical Decision Support for Individualized Cancer Risk Management 5U24CA274582-03 Christos Patriotis, Ph.D., M.Sc.
Feng, Ziding

Fred Hutchinson Cancer Center
United States

Consortium on Translational Research in Early Detection of Liver Cancer:Data Management and Coordinating Center (DMCC) 5U24CA230144-09 Guillermo Marquez, Ph.D.
Kleckner, Amber Simmons

University Of Maryland Baltimore
United States

Time-restricted eating to address cancer-related fatigue among survivors of hematological malignancies 5R01CA284082-02 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Zhou, Xianghong Jasmine

University Of California Los Angeles
United States

Multi-cancer early detection using cell-free DNA methylome analysis 5U01CA285010-03 Nicholas Hodges, Ph.D.
Wang, Kai

Massachusetts General Hospital
United States

Dietary prevention for colorectal cancer: targeting the bile acid/gut microbiome axis 4R00CA283146-03 Amit Kumar, Ph.D.
Salipante, Stephen J

University Of Washington
United States

Efficient, cost-effective, and ultrasensitive sequencing of somatic mutations and methylation 1R33CA302385-01 Nicholas Hodges, Ph.D.
Chen, Ru

Baylor College Of Medicine
United States

BLOOD-BASED PROTEOMIC ASSAY FOR PANCREATIC CANCER DETECTION 4UH3CA292130-02 Claire Zhu, Ph.D.
Robertson, Sarah E

Dartmouth College
United States

Learning about the effectiveness of lung cancer screening in real-world target populations 4R00CA287059-03 Neeraj Saxena, Ph.D.
Papadopoulos, Nickolas

Johns Hopkins University
United States

Multi-analyte Approach for Earlier Detection of Cancers in Non Plasma Biofluids 5U01CA230691-08 Nicholas Hodges, Ph.D.
Skates, Steven J

Massachusetts General Hospital
United States

Genome-wide methylation and proteomic analysis of uterine lavage and cervical swab for early detection of ovarian cancer 5U2CCA271871-03 Christos Patriotis, Ph.D., M.Sc.
Duncavage, Eric J

Washington University
United States

Whole Genome Sequencing for Genomic Evaluation and Risk Stratification of Patients with Myelodysplastic Syndromes 4UH3CA272904-02 Nicholas Hodges, Ph.D.
Heine, John J

H. Lee Moffitt Cancer Ctr & Res Inst
United States

Quantitative Imaging Clinical Validation Center at Moffitt Cancer Center 5U01CA200464-08 Guillermo Marquez, Ph.D.
Bergan, Raymond C.

University Of Nebraska Medical Center
United States

Preventing invasive prostate cancer 3R01CA276846-03S1 John Clifford, Ph.D.
Wong, David T

University Of California Los Angeles
United States

EFIRM Liquid Biopsy Research Laboratory: Early Lung Cancer Assessment 4U01CA233370-08 Nicholas Hodges, Ph.D.
Singal, Amit

Ut Southwestern Medical Center
United States

Precision Risk Stratification and Screening for HCC among Patients with Indeterminate Liver Nodules 4U01CA283935-03 Sidney Fu, M.D.
Kuhn, Peter

University Of Southern California
United States

Multi-modal Liquid Biopsy Early Assessment of Breast Cancer, Pancreatic Cancer, and Multiple Myeloma 4U01CA285013-03 Nicholas Hodges, Ph.D.
Arnold, Corey Wells

University Of California Los Angeles
United States

Computational Feature Profiling and Modeling for Prostate Cancer Detection and Risk Stratification 5R01CA279666-03 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Panigrahy, Dipak

Beth Israel Deaconess Medical Center
United States

Control of cancer cachexia via stimulation of resolution of inflammation 5R01CA276107-03 Marjorie Perloff, M.D.
Giles, Erin

University Of Michigan At Ann Arbor
United States

Obesity, body fat distribution, and breast cancer risk: is visceral fat the culprit after menopause? 5R01CA269726-03 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Marjorie Perloff, M.D.
Mcguire, Andrew

Fred Hutchinson Cancer Center
United States

Rational Vaccine Design to prevent HIV-Associated Lymphoma 5R01CA285227-03 Anda Vlad, M.D., Ph.D.
You, Ming

Methodist Hospital Research Institute
United States

Targeting phenethyl isothiocyanate to mitochondria in lung carcinogenesis 5R01CA280746-03 John Clifford, Ph.D.
Torres, Keila Enitt

University Of Tx Md Anderson Can Ctr
United States

Use of Noninvasive Biomarkers and Advanced MRI for early detection of NF1-associated MPNSTs 5R01CA285980-02 Guillermo Marquez, Ph.D.
Huh, Warner King

University Of Alabama At Birmingham
United States

Misoprostol to Optimize Prevention of Cancer of the Cervix: A Randomized Trial (MISOPCx Project) 3R01CA279021-02S1 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Badve, Sunil S.

Emory University
United States

Early prediction of lethal phenotypes in triple negative breast cancer using multiscale, multi-modality platforms 5R01CA281932-02 Wendy Wang, Ph.D., M.Sc.
Xu, Xiangxi Mike

University Of Miami School Of Medicine
United States

Countering microtubule stabilization within hair follicles in ovarian cancer chemotherapy 5R01CA286527-02 Rachel Altshuler, Ph.D.
Moscicki, Anna-Barbara

University Of California Los Angeles
United States

Real-world effectiveness of HPV vaccine in women living with HIV and its impact on cervical cancer screening accuracies 5R01CA281293-03 Maria Silvina Frech, Ph.D., M.S.
Jacob, Jennifer B

Henry Ford Health + Michigan State University Health Sciences
United States

Defining Cancer Intervention Targets by Functional Genomics Analysis of Outbred F1 Mice 5R01CA278818-03 Anda Vlad, M.D., Ph.D.
Hui, David

University Of Tx Md Anderson Can Ctr
United States

Strategies for Personalizing Oxygen and support Therapies for dyspnea in Oncology 5R01CA288515-02 Brennan Streck, Ph.D., RN, M.P.H.
Bower, Julienne E

University Of California Los Angeles
United States

Mindfulness Meditation for Younger Breast Cancer Survivors: Testing Digital Interventions in Clinical and Community Settings 5R01CA282416-02 Brennan Streck, Ph.D., RN, M.P.H.
Mosher, Catherine E

Indiana University Indianapolis
United States

Acceptance and Commitment Therapy for Patient Fatigue Interference and Caregiver Burden in Advanced Gastrointestinal Cancer 5R01CA289486-02
Cohen, Lorenzo

University Of Tx Md Anderson Can Ctr
United States

Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery 5R01CA272565-03 Brennan Streck, Ph.D., RN, M.P.H.
Veiseh, Omid

Rice University
United States

Bioengineered lymphatic regenerating platform for treatment of breast cancer related lymphedema 1R01HL179534-01 Goli Samimi, Ph.D., M.P.H.
Wright, Alexi A

Dana-Farber Cancer Inst
United States

Randomized trial of REVITALIZE: A telehealth intervention to reduce fatigue interference among adults with advanced ovarian cancer on PARP inhibitors 5R01CA289547-02 Goli Samimi, Ph.D., M.P.H.
Kanarek, Naama

Boston Children'S Hospital
United States

Mechanistic Study of Methotrexate-Induced Oxidative Distress in Neurons and the CSF 5R01CA282477-02 John Clifford, Ph.D.
Kirkwood, Kimberly Saunders

University Of California, San Francisco
United States

Using microvolumetric cyst fluid proteolysis for early detection of pancreatic cancer 5U01CA282269-02 Matthew Young, Ph.D.
Ahn, Eun Hyun

Johns Hopkins University
United States

Engineered biomimetic collective cancer invasion models for screening chemotherapeutic agents 5R01CA279948-02 Guillermo Marquez, Ph.D.
Jang, Mi-Hyeon

Rutgers Biomedical And Health Sciences
United States

Identification of novel biomarkers and therapeutic strategies in chemobrain. 5R01CA293210-02 John Clifford, Ph.D.
Mao, Jun J

Sloan-Kettering Inst Can Research
United States

Enhanced Pain Coping in Cancer (EPIC) 5R01CA285746-02 Rachel Altshuler, Ph.D.
Reese, Jennifer Barsky

Research Inst Of Fox Chase Can Ctr
United States

Promoting Effective Clinical Communication about Sexual Health after Gynecologic Cancer: A Randomized Controlled Trial of a Patient-Focused Intervention 5R01CA285674-02 Vanessa A. White, M.P.H.
Wang, Thomas D

University Of Michigan At Ann Arbor
United States

Peptide multimer for early detection of hepatocellular carcinoma 5R01CA285303-02 Guillermo Marquez, Ph.D.
Seguin-Fowler, Rebecca Anne

Texas A&M Agrilife Research
United States

Deep in the Heart for Women: A Community-Engaged Intervention Study to Catalyze a Culture of Health in Rural South Texas 1R01HL179449-01 Goli Samimi, Ph.D., M.P.H.
Nyamathi, Adeline M

University Of California-Irvine
United States

Secondary Cervical Cancer Prevention of Vulnerable Women with HPV and HIV Co-infection in India 3R01CA285063-03S2 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Schaverien, Mark V

University Of Tx Md Anderson Can Ctr
United States

Lymphedema Prevention Through Immediate Lymphatic Reconstruction 5R01CA292908-02 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Rini, Christine

Northwestern University At Chicago
United States

Mosaic: RCT of a Digital Health Intervention Delivering Peer Support Narratives and Psychoeducation to English- and Spanish-Speaking Stem Cell Transplant Recipients 5R01CA292116-02 Brennan Streck, Ph.D., RN, M.P.H.
Tearney, Guillermo J

Massachusetts General Hospital
United States

Colorectal Cancer Screening with Optical Coherence Tomography 5R01CA280972-02 Matthew Young, Ph.D.
Daniel-Macdougall, Carrie

University Of Tx Md Anderson Can Ctr
United States

Prebiotic diet intervention to enhance the microbiome and immunotherapy response in melanoma 5R01CA291965-02 Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Winger, Joseph Giles

Duke University
United States

Engage: A Randomized Controlled Trial Testing the Efficacy of a Telehealth-Delivered Psychosocial Intervention to Decrease Symptom Interference in Patients with Advanced Cancer 5R01CA291768-02 Brennan Streck, Ph.D., RN, M.P.H.
Flynn, Kathryn E

Medical College Of Wisconsin
United States

Symptom Monitoring using Patient-Reported Outcomes to Optimize Medication Use (SyMPTOM) 5R01CA285925-02 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Prigerson, Holly Gwen

Weill Medical Coll Of Cornell Univ
United States

Behavioral and Psychosocial Effects on Study Outcomes in End-Stage Cancer Treatment (BEST End-Stage Cancer Study) 5R35CA197730-11 Brennan Streck, Ph.D., RN, M.P.H.
Klopp, Ann

University Of Tx Md Anderson Can Ctr
United States

Defining a globally accessible and pragmatic predictive signature (GAPPS) for locally advanced cervical cancer 1R01CA301124-01 Goli Samimi, Ph.D., M.P.H.
Sen, Subrata

University Of Tx Md Anderson Can Ctr
United States

Circulating Biomarkers and Imaging for Early Detection of Pancreatic Cancer 5U01CA214263-07 Matthew Young, Ph.D.
Simeone, Diane M

University Of California, San Diego
United States

Biomarker Validation in Pancreatic Cystic Neoplasms 5U01CA282272-03 PAR-21-334 (U01 Clinical Trial Optional) Matthew Young, Ph.D.
Flowers, Lisa C.

Emory University
United States

Screening Strategies Among High-Risk Populations for Anal Cancer 5R01CA285198-03 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Sands, Stephen Alan

Sloan-Kettering Inst Can Research
United States

Prospective international phase-III study to improve neurocognitive outcomes in young children with low-risk medulloblastoma (YCMB-LR) 5R01CA283045-02 PAR-21-329 (R01 Clinical Trial Optional) Marjorie Perloff, M.D.
Mu, Ping

Yale University
United States

Unveiling the Role of UBE2J1 as the E2 Ubiquitin Conjugating Enzyme in Androgen Receptor Degradation 5R01CA292949-03 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Yang, Qing

University Of Texas Med Br Galveston
United States

The role of acute excitation of sensory neurons in the development of paclitaxel-induced peripheral neuropathy 5R01CA273001-02 Rachel Altshuler, Ph.D.
Gonzalez, Brian D

H. Lee Moffitt Cancer Ctr & Res Inst
United States

Impact of Targeted Therapy on Cancer-Related Cognitive Impairment 5R01CA287666-02 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Ji, Hanlee P

Stanford University
United States

Single-molecule nanopore-based identification of methylome signatures in cfDNA for early colorectal cancer detection 5U01CA282212-02 Claire Zhu, Ph.D.
Cai, Long

California Institute Of Technology
United States

Understanding the role of tumor microenvironment in low grade glioma progression to malignancy 4U01CA294551-02 Sidney Fu, M.D.
Wang, Linghua

University Of Tx Md Anderson Can Ctr
United States

Center for Gastric Pre-Cancer Atlas of Multidimensional Evolution in 3D (GAME3D) 4U01CA294518-02 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Kanetsky, Peter A

H. Lee Moffitt Cancer Ctr & Res Inst
United States

A hybrid effectiveness-implementation trial to integrate precision skin cancer risk feedback in federally qualified health centers 5R01CA291735-02 Claire Zhu, Ph.D.
Sears, Rosalie C

Oregon Health & Science University
United States

An atlas of pancreatic tumorigenesis in the context of altered DNA repair occurring in high-risk individuals 4U01CA294548-02 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Huang, Yijian

Emory University
United States

Analytic diagnosis methods for disease ruling 5R01CA283687-02 Guillermo Marquez, Ph.D.
Bartolini, Francesca

Columbia University Health Sciences
United States

Investigating the Pathogenic Role of Tubulin Post-translational Modifications in CIPN 5R01CA279401-02 Rachel Altshuler, Ph.D.
Richards-Kortum, Rebecca R.

Rice University
United States

Sample-to-answer HPV DNA nucleic acid test for cervical cancer screening in Mozambique 3U01CA292741-02S1 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Shain, Alan Hunter

University Of California, San Francisco
United States

Pre-cancer atlas of skin cancer 4U01CA294536-02 Nicholas Hodges, Ph.D.
Marker, Ryan J

University Of Colorado Denver
United States

Effects of a telehealth exercise program for rural cancer survivors with cancer-related fatigue including integrated longitudinal assessments of objective physical function and fatty acid oxidation 5R01CA292482-02 Goli Samimi, Ph.D., M.P.H.
Kelleher, Sarah

Duke University
United States

Randomized Controlled Trial of a Hybrid-Delivered Cognitive Behavioral Symptom Management and Activity Coaching Intervention for Stem Cell Transplant Patients 5R01CA291888-02 Brennan Streck, Ph.D., RN, M.P.H.
Lowry, Kathryn Paige

University Of Washington
United States

Evaluation of Commercial Mammography-Based Artificial Intelligence Algorithms for Breast Cancer Risk Prediction in U.S. Screening Populations 5R37CA292399-02 Claire Zhu, Ph.D.
Santomasso, Bianca Denise

Sloan-Kettering Inst Can Research
United States

Comprehensive Molecular and Clinical Characterization of Acute and Chronic Neurotoxicity Following CAR-T Cell Therapy 5R01CA293922-02 Monica Epstein, B.S.N., RN, OCN
Ghobrial, Irene M.

Dana-Farber Cancer Inst
United States

Myeloma multidimensional precancer atlas 4U01CA294507-02 Nicholas Hodges, Ph.D.
Banerjee, Imon

Mayo Clinic Arizona
United States

Multimodal AI Fusion Model for Early Detection for Pancreatic Cancer 5R01CA289249-02 Nicholas Hodges, Ph.D.
Esserman, Laura J

University Of California, San Francisco
United States

WISDOM: A platform to optimize subtype-specific screening and prevention 5P01CA281826-02 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Warner, Erica T

Massachusetts General Hospital
United States

Aspirins legacy on cancer and overall benefit: risk balance over a 15-year horizon 3U01CA301988-02S1 Asad Umar, D.V.M., Ph.D.
Wildman-Tobriner, Benjamin

Duke University
United States

AI for Differentiation of Low vs High Risk Thyroid Nodules on Ultrasound 1R01CA297227-01A1 Wendy Wang, Ph.D., M.Sc.
Guo, Xingyi

Vanderbilt University Medical Center
United States

Leveraging Omics and Electronic Health Records Data to study Colorectal Adenoma genetics and Drug Repurposing 1R01CA297582-01A1 Gary Della'Zanna, D.O., M.Sc.
Hoshida, Yujin

Ut Southwestern Medical Center
United States

Epigallocatechin gallate for prevention of lethal cirrhosis complications 5R01CA282178-02 Asad Umar, D.V.M., Ph.D.
Hsu, Li

Fred Hutchinson Cancer Center
United States

Statistical Methods for Precision Prevention 5R01CA297681-02 Claire Zhu, Ph.D.
Tennis, Meredith A

University Of Colorado Denver
United States

Persistence and regression in lung premalignant lesions 5R01CA289576-02 Malgorzata Wojtowicz, M.D.
Mehta, Anand S.

Medical University Of South Carolina
United States

Glycan Biomarkers for Cholangiocarcinoma 5R01CA289381-02 Sidney Fu, M.D.
Elmore, Joann G

University Of California Los Angeles
United States

Optimizing the Human-Computer Interaction in Pathology: Understanding the Impact of Computer-Aided Diagnosis Tools on Pathologists' Interpretive Performance 5R01CA288824-02 Claire Zhu, Ph.D.
Chiang, Cheng-Ming

Ut Southwestern Medical Center
United States

Small Compound Inhibitors Targeting HPV Genome Replication 5R01CA288743-02 Anda Vlad, M.D., Ph.D.
Kassie, Fekadu

University Of Minnesota
United States

Targeting tumor cell mitochondria for the prevention and treatment of lung cancer 5R01CA285608-02 John Clifford, Ph.D.
Jobin, Christian

University Of Florida
United States

Interaction between dietary taurine and microbiota sulfur metabolism in the development of colorectal cancer 5R01CA296643-02 Young Kim, Ph.D.
Debes, Jose Daniel

University Of Minnesota
United States

Biomarkers for Early Detection of Hepatitis B-Related Hepatocellular Carcinoma in Hispanics 1R37CA297814-01 Sidney Fu, M.D.
Muzumdar, Mandar Deepak

Yale University
United States

Targeting pancreatic endocrine-exocrine signaling in cancer development with incretin mimetics 5R01CA296916-02 Anda Vlad, M.D., Ph.D.
Markowitz, Sanford D.

Case Western Reserve University
United States

A Clinical Trial of Cancer Prevention by Biomarker Based Detections of Barrett's Esophagus and Its Progression 5R01CA295877-02 Asad Umar, D.V.M., Ph.D.
Garcia, Jose M.

Seattle Inst For Biomedical/Clinical Res
United States

SArcopenia in Men with Prostate Cancer undergoing ADT (SAP-ADT) 5R01CA279220-03 Marjorie Perloff, M.D.
Kang, Dongkyun

University Of Arizona
United States

Non-invasive, quantitative microscopic biomarkers for chemotherapy-induced peripheral neuropathy 1R01CA301271-01 Rachel Altshuler, Ph.D.
Klein, Alison P

Johns Hopkins University
United States

Improving Management of patients at High Risk of Pancreatic Cancer 5R01CA299421-02 Matthew Young, Ph.D.
Tewari, Ashutosh K

Icahn School Of Medicine At Mount Sinai
United States

Artificial intelligence enabled Stroma-Weighted Automated Grading system to improve risk stratification in Black Men 1R01CA290438-01A1 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Tennis, Meredith A

University Of Colorado Denver
United States

Modeling lung squamous cell carcinoma premalignancy and prevention 1R01CA298925-01
Kim, Michelle Kang

Cleveland Clinic Lerner Com-Cwru
United States

Assessing feasibility of gastric cancer screening in the US 1R37CA300540-01 Claire Zhu, Ph.D.
Crowder, Sylvia

H. Lee Moffitt Cancer Ctr & Res Inst
United States

The MIND-BC Study: MIND diet for Breast cancer Cognition 1R01CA299480-01 Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Eisenmann, Eric Daniel

Ohio State University
United States

Damage-associated molecular patterns in chemotherapy toxicity 1R37CA299879-01 Rachel Altshuler, Ph.D.
Kisiel, John

Mayo Clinic Rochester
United States

Multi-cancer Early Detection 2R01CA214679-08 Matthew Young, Ph.D.
Deng, Jie

University Of Pennsylvania
United States

Placebo-Controlled Phase II Randomized Clinical Trial of Photobiomodulation Therapy in Head and Neck Cancer Survivors with Chronic Lymphedema 1R01CA289307-01A1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Germain, Doris A

Icahn School Of Medicine At Mount Sinai
United States

Investigating the efficacy of g-Tocotrienol for the prevention of post-partum breast cancer 1R01CA301372-01 Anda Vlad, M.D., Ph.D.
Castilla, Lucio H.

Univ Of Massachusetts Med Sch Worcester
United States

Study of tyrosine kinase inhibitors as preventive therapy in RUNX1-FPD 1U01CA296350-01 Marjorie Perloff, M.D.
Backman, Vadim

Northwestern University At Chicago
United States

Optical hyperspectral nanoscale chromatin analysis for colon cancer risk-stratification 1R01CA289294-01A1 Claire Zhu, Ph.D.
Bissonnette, Bruce Marc

University Of Chicago
United States

A non-invasive blood test for multi-cancer detection and determination of tissue of origin preceding overt cancer diagnosis 1U01CA297685-01 Claire Zhu, Ph.D.
Butryn, Meghan

Drexel University
United States

Efficacy of a multi-level intervention designed to promote adherence to WCRF/AICR dietary guidelines for cancer prevention 1R01CA288323-01A1 Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Cao, Weidan

Ohio State University
United States

Treatment-Related Cardiotoxicity Risk Prediction for Breast Cancer Patients with a Multimodal AI-based System 1R01CA301579-01 Eileen Dimond, R.N., M.S.
Siskind, Leah J

University Of Louisville
United States

Protecting the kidney from cisplatin induced injury and progression to chronic kidney disease 1R01CA305985-01 Marjorie Perloff, M.D.
Iyer, Prasad G.

Mayo Clinic Arizona
United States

Minimally Invasive Molecular Approaches for the Detection of Barrett’s Esophagus and Esophageal Adenocarcinoma 2R01CA241164-07 Matthew Young, Ph.D.
Howitt, Brooke E

Stanford University
United States

Unraveling heterogeneity in endometrial cancer via integrated single cell genotype-phenotype mapping 1R37CA303960-01 Goli Samimi, Ph.D., M.P.H.
Zheng, Qin

Johns Hopkins University
United States

Determining the function of medium to large diameter sensory neurons in paclitaxel-induced pain via large-scale in vivo DRG imaging 1R01CA291906-01A1 Rachel Altshuler, Ph.D.
Mana, Miyeko

Arizona State University-Tempe Campus
United States

Influence of developmental programming in adult stem cells and cancer 1R01CA301086-01 Young Kim, Ph.D.
Gill, Brian John Andrew

Columbia University Health Sciences
United States

The Impact of Local and Reversible Change to GABAergic Inhibitory Signaling on Tumor-Induced Cortical Dysfunction in Glioma 1R01NS140658-01A1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Leslie, Kimberly K.

University Of New Mexico Health Scis Ctr
United States

Advancing Hormone Therapy for Endometrial Cancer 1P01CA278735-01A1 Goli Samimi, Ph.D., M.P.H.
Morin, Olivier

University Of California, San Francisco
United States

Development of a Personalized Voxel-wise Prediction of Brain Metastases using Multi-Parametric MR Imaging to Reduce Treatment Toxicity 1R01CA292043-01A1 Marjorie Perloff, M.D.
Upshaw, Jenica

Beth Israel Deaconess Medical Center
United States

A randomized trial of cardioprotective strategies in newly diagnosed diffuse large B-cell lymphoma and pre-existing cardiomyopathy or prior anthracycline exposure 1R37CA300969-01 Eileen Dimond, R.N., M.S.
Czerniak, Bogdan A

University Of Tx Md Anderson Can Ctr
United States

Mechanisms of Bladder Cancer Development and Its Therapeutic Vulnerabilities to Preventive and Interventive Therapy. 1P01CA296429-01A1 Howard L. Parnes, M.D.
Goel, Ajay

Beckman Research Institute/City Of Hope
United States

5mC and 5hmC DNA alterations as sensitive and specific biomarkers for the non-invasive early detection of pancreatic ductal adenocarcinoma 1U01CA296639-01A1 Claire Zhu, Ph.D.
Ostrin, Edwin Justin

University Of Tx Md Anderson Can Ctr
United States

Validation of blood-based biomarkers for risk assessment of lung cancer among individuals with no smoking history in the PLCO Cohort 1U01CA295902-01A1 Claire Zhu, Ph.D.
Zhao, Yingqi

Fred Hutchinson Cancer Center
United States

Developing methods for advancing the early detection of pancreatic ductal adenocarcinoma leveraging electronic medical records data 1R01CA289668-01A1 Matthew Young, Ph.D.
Hutson, Alan David

Roswell Park Cancer Institute Corp
United States

Cancer Immunoprevention Network (CIP-Net) Resource Coordinating Center 1U24CA305623-01 Altaf Mohammed, Ph.D.
Perez-Lougee, Giselle Katiria

Massachusetts General Hospital
United States

Thriving Beyond Treatment: A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship 1R37CA303094-01 Marjorie Perloff, M.D.
Mungo, Chemtai

Univ Of North Carolina Chapel Hill
United States

Expanded Safety and Preliminary Efficacy of Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women with HIV in Africa 3R37CA306827-01S2 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Thompson, Patricia Ann

University Of Arizona
United States

University of Arizona Cancer Prevention Clinical Trials Network 2UG1CA242596-07 Donald Johnsey
Sanchez, Eduardo Vilar

University Of Tx Md Anderson Can Ctr
United States

iCAN PREVENT: MD Anderson International Cancer Prevention Clinical Trials Consortium 2UG1CA242609-07 Donald Johnsey
Schuetze, Scott Michael

University Of Michigan At Ann Arbor
United States

Early Phase Clinical Cancer Prevention Consortium 2UG1CA242632-06 Donald Johnsey
Khan, Seema Ahsan

Northwestern University At Chicago
United States

Northwestern Cancer Prevention Consortium 2UG1CA242643-07 Donald Johnsey
Eickhoff, Jens

University Of Wisconsin-Madison
United States

CP-CTNet Coordinating Center 1UG1CA304955-01 Donald Johnsey